Age-dependent instability of mature neuronal fate in induced neurons from Alzheimer’s patients
Open accessAbstract
Sporadic Alzheimer's disease (AD) exclusively affects elderly people. Using direct conversion of AD patient fibroblasts into induced neurons (iNs), we generated an age-equivalent neuronal model. AD patient-derived iNs exhibit strong neuronal transcriptome signatures characterized by downregulation of mature neuronal properties and upregulation of immature and progenitor-like signaling pathways. Mapping iNs to longitudinal neuronal differentiation trajectory data demonstrated that AD iNs reflect a hypo-mature neuronal identity characterized by markers of stress, cell cycle, and de-differentiation. Epigenetic landscape profiling revealed an underlying aberrant neuronal state that shares similarities with malignant transformation and age-dependent epigenetic erosion. To probe for the involvement of aging, we generated rejuvenated iPSC-derived neurons that showed no significant disease-related transcriptome signatures, a feature that is consistent with epigenetic clock and brain ontogenesis mapping, which indicate that fibroblast-derived iNs more closely reflect old adult brain stages. Our findings identify AD-related neuronal changes as age-dependent cellular programs that impair neuronal identity.
AI snapshot
Written from the paper’s full text.
TL;DR
Directly converted induced neurons (iNs) from Alzheimer’s disease patients retain age-equivalent neuronal identity and show a hypo-mature, de-differentiated state with loss of mature neuronal gene expression and functional deficits. This AD-related instability is age-dependent: rejuvenated iPSC-derived neurons from the same patients show no significant disease transcriptome signature.
Key findings
- AD iNs had 778 highly significant DE genes (FDR < 0.01), while parental fibroblasts showed no significant AD-specific DE genes; AD iN transcriptomes overlapped with post-mortem AD brain and neuronal single-nucleus AD signatures.
- Downregulated genes in AD iNs were enriched for mature neuronal categories including synaptic transmission, oxidative phosphorylation, neuronal action potential, ion transport, and mitochondria; AD iNs showed reduced dendritic complexity, fewer synapsin and synapsin/PSD-95 puncta, and reduced spontaneous Ca²⁺ event frequency.
- Upregulated genes in AD iNs were enriched for cell cycle, stem/progenitor maintenance, stress, apoptosis, senescence, and cancer-related pathways; ATAC-seq showed on average 36% more open chromatin peaks that were 7% wider, with 7,188 differentially accessible peaks, 97% gained in AD.
- Rejuvenated iPSC-derived neurons showed no significant DE genes between control and AD subjects; iN DNA methylation ages reflected donor adult/old ages, whereas iPSC derivatives reflected pre-natal ages, and AD iNs did not show accelerated epigenetic aging over controls.
Methods
- Fibroblasts from 16 AD subjects (13 sporadic, 3 familial) and 19 age- and sex-matched non-demented controls were directly converted into iNs using Ngn2/Ascl1-based, small-molecule-enhanced conversion and PSA-NCAM FACS isolation.
- Assays included whole-genome RNA-seq, ATAC-seq, DNA methylation EPIC arrays, immunofluorescence, ELISA for Aβ42/40, ROS measurement, live-cell Ca²⁺ imaging, and morphological reconstruction.
- A subset (n = 20) was reprogrammed to iPSCs and converted to iPSC-iNs as rejuvenated isogenic controls; transcriptomes were compared with post-mortem bulk and single-nucleus AD data, BrainSpan fetal/adult brain samples, and published neuronal differentiation trajectories.
Limitations
- Stated in the paper: fibroblasts carry skin-specific, age-related changes that might interfere with AD-related iN changes; some brain-specific changes might not be captured; Ngn2/Ascl1 overexpression might override endogenous differences; other iPSC differentiation models might recapitulate AD phenotypes more prominently; and the cohort might not fully represent all AD patients.
- Evident from the text: the model is in vitro and fibroblast-derived, and although AD iNs showed cell cycle re-entry markers and increased DNA content above diploid, no completed neuronal DNA replication was detected, so conclusions about cell cycle re-entry rely on markers and aneuploidy rather than completed division.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 57 cited sources checked · 0 supported · 0 flagged
- Findingown data
AD iNs reflect a hypo-mature neuronal identity characterized by markers of stress, cell cycle, and de-differentiation.
“Mapping iNs to longitudinal neuronal differentiation trajectory data demonstrated that AD iNs reflect a hypo-mature neuronal identity characterized by markers of stress, cell cycle, and de-differentiation.”
Quote in the paperSubstantial claim - Findingown data
AD iNs showed a reduced frequency of Ca2+ neuronal activity events compared with control iNs.
“We used GcAMP6m-based live-cell Ca2+ imaging to assess spontaneous neuronal activity, and we detected a reduced frequency of Ca2+ neuronal activity events in AD iNs (Figures 3I and 3J).”
Quote in the paperSubstantial claim - Findingnone given
These GO and KEGG categories were also enriched within upregulated genes in post-mortem AD data.
“These GO and KEGG categories were also enriched within upregulated genes in post-mortem AD data.”
Quote in the paperSubstantial claim - Findingown data
These top-ranked downregulated categories were also enriched within downregulated genes in post-mortem AD, indicating a loss of genes promoting neuronal differentiation.
“These top-ranked categories were also enriched within downregulated genes in post mortem AD, further indicating a loss of genes promoting the differentiation of neurons (Figure 3B; Table S5).”
Quote in the paperSubstantial claim - Findingown data
GSEA of the most significantly upregulated AD iN DE genes indicated enrichment for cell cycle control, stem/progenitor cell maintenance, signal transduction pathways, apoptosis, and cancer-related pathways.
“GSEA of the most significantly (padj < 0.01) upregulated AD iN DE genes indicated that these genes were enriched for a broad semantic spectrum around cell cycle control, stem/progenitor cell maintenance, signal transduction pathways, apoptosis, and cancer-related pathways (Figure 4A; Table S5).”
Quote in the paperSubstantial claim
- Findingown data
PSA-NCAM-positive FACS-purified AD iN cultures displayed less complex dendritic morphologies than control iNs.
“Consistent with the transcriptional changes, PSA-NCAM-positive FACS-purified AD iN cultures displayed less complex dendritic morphologies, as revealed by βIII-tubulin-based reconstructions (Figures 3E and 3F).”
Quote in the paperSubstantial claim - Findingreasoning
Fibroblast-derived iNs more closely reflect old adult brain stages than rejuvenated iPSC-derived neurons.
“To probe for the involvement of aging, we generated rejuvenated iPSC-derived neurons that showed no significant disease-related transcriptome signatures, a feature that is consistent with epigenetic clock and brain ontogenesis mapping, which indicate that fibroblast-derived iNs more closely reflect old adult brain stages.”
Quote in the paperSubstantial claim - Findingown data
Epigenetic landscape profiling revealed an underlying aberrant neuronal state that shares similarities with malignant transformation and age-dependent epigenetic erosion.
“Epigenetic landscape profiling revealed an underlying aberrant neuronal state that shares similarities with malignant transformation and age-dependent epigenetic erosion.”
Quote in the paperSubstantial claim - Findingown data
Rejuvenated iPSC-derived neurons showed no significant disease-related transcriptome signatures.
“To probe for the involvement of aging, we generated rejuvenated iPSC-derived neurons that showed no significant disease-related transcriptome signatures, a feature that is consistent with epigenetic clock and brain ontogenesis mapping, which indicate that fibroblast-derived iNs more closely reflect old adult brain stages.”
Quote in the paperSubstantial claim - Findingown data
No systematic differences were observed between iNs from sporadic and familial AD patients based on mature neuronal marker genes.
“On the basis of these marker genes, we did not observe systematic differences between iNs from sporadic and familial AD patients (Figure S1).”
Quote in the paperNot a substantial claim - Findingown data
Gene categories enriched in the most significantly downregulated AD genes covered nervous system development, neuronal action potential, synaptic transmission, ion transport, and mitochondria.
“GSEA indicated that gene categories enriched in the most significantly (padj < 0.01) downregulated AD genes covered a semantic space around nervous system development, neuronal action potential, synaptic transmission, ion transport, and mitochondria (Figure 3A).”
Quote in the paperSubstantial claim - Findingown data
No signs of increased neuronal cell death were detected in AD iNs under standard culture conditions.
“No signs of increased neuronal cell death were detected in AD iNs under standard culture conditions (not shown).”
Quote in the paperNot a substantial claim - Findingown data
These functionally active iN cultures consisted primarily of glutamatergic (vGlut1+) neurons and a minor fraction of GABA+ neurons.
“These functionally active cultures consisted primarily of glutamatergic (vGlut1+) neurons and a minor fraction of GABA+ neurons (Figures 1F and 1G; Figure S1).”
Quote in the paperNot a substantial claim - Findingown data
The density of synapsin-positive and synapsin/PSD-95 co-labeled synapse-like structures along neurites of AD iNs was significantly reduced compared with control iNs.
“Furthermore, the density of synapsin-positive and synapsin/PSD-95 co-labeled synapse-like structures along the neurites of AD iNs was significantly reduced compared with control iNs (Figures 3G and 3H).”
Quote in the paperSubstantial claim - Findingown data
Only iNs from familial AD patients showed increased Aβ42/40 ratios in conditioned media.
“As expected, only iNs from the familial AD patients showed increased Aβ42/40 ratios in conditioned media (Figure 1I).”
Quote in the paperNot a substantial claim - Findingown data
Representative mature neuronal gene sets and marker genes, including synaptic plasticity and NRFS/REST targets, were markedly downregulated in AD iNs.
“Then we tested representative, previously defined mature neuronal gene sets and corresponding marker genes, including synaptic plasticity and NRFS/REST targets, that were markedly downregulated in AD iNs (Figures 4C and 4D; Kim et al., 2015; Satoh et al., 2013).”
Quote in the paperSubstantial claim - Findingown data
No significant differentially expressed genes are detected between iPSC-iNs of control and AD subjects.
“No significant DE genes were detected between iPSC-iNs of control and AD subjects (Figure 7F).”
Quote in the paperSubstantial claim - Findingown data
AD iNs displayed increased levels of total ROS.
“Indeed, AD iNs displayed increased levels of total ROS (Figure 5A), and we also detected changes in DNA damage repair-related gene expression and increased numbers of nuclear H2A.X-positive foci in AD iN nuclei (Figure S2).”
Quote in the paperSubstantial claim - Findingown data
Global gene expression of fibroblasts, iNs, iPSCs, and iPSC-iNs separates clearly by cell type in tSNE and PCA.
“Data reduction using tSNE and PCA on the global gene expression of all four cell types together resulted in clear separation by cell type (Figure 7C; Figure S1).”
Quote in the paperNot a substantial claim - Findingnone given
Isogenic iPSC-derived neurons show only very dampened AD transcriptome changes.
“Isogenic iPSC-derived neurons show only very dampened AD transcriptome changes”
Quote in the paperSubstantial claim - Findingown data
Differential expression analysis between fibroblasts and iNs and between iPSCs and iPSC-iNs reveals many overlapping neuronal GO terms equally enriched in iNs and iPSC-iNs.
“DE analysis between all fibroblast and iN samples, and between all iPSC and iPSC-iN samples, revealed many overlapping neuronal GO terms equally enriched in iNs and iPSC-iNs (Figure S5; Table S7).”
Quote in the paperSubstantial claim - Findingown data
Genes with both the most significantly increased ATAC-seq promoter-TSS accessibility and increased RNA-seq expression in AD iNs were enriched in KEGG pathways associated with cancer, metabolic pathways, and apoptosis.
“GSEA revealed that the genes with both the most significantly increased ATAC-seq promoter-TSS accessibility and increased RNA-seq expression in AD iNs were enriched KEGG pathways associated with cancer, metabolic pathways, and apoptosis (Figure 6G).”
Quote in the paperSubstantial claim - Findingown data
Peak scoring showed a marked increase in chromatin accessibility in AD iNs around identified peaks.
“Peak scoring showed a marked increase in chromatin accessibility in AD iNs around identified peaks (Figure 6D; Figure S4).”
Quote in the paperSubstantial claim - Findingown data
No completed neuronal DNA replication was detected in iNs.
“Within the AD iN group, we observed slightly more neurons with both lower and higher DNA content, with the increase of AD iNs over the diploid level being significant (Figure S2), but we could not detect a completed neuronal DNA replication in iNs (Figures 5E and 5F; Figure S2).”
Quote in the paperSubstantial claim - Findingown data
LDHA mRNA and protein levels were significantly upregulated in AD iNs.
“We found LDHA mRNA and protein levels to be significantly upregulated in AD iNs (Figure 4E; Figures 5H and 5I; Figure S2).”
Quote in the paperSubstantial claim - Findingown data
Direct comparison of epigenetic landscapes of AD and control iNs to longitudinal timeline ATAC-seq data of neuronal differentiation from iPSCs confirmed that AD iN peak profiles better resembled less mature stages during neural iPSC differentiation.
“Furthermore, direct comparison of the epigenetic landscapes of AD and control iNs to longitudinal timeline ATAC-seq data of neuronal differentiation from iPSCs (Zhang et al., 2018) confirmed that AD iN peak profiles better resembled less mature stages during neural iPSC differentiation (Figure S4).”
Quote in the paperSubstantial claim - Findingown data
Gene sets that best characterize dysregulation in AD iNs show a consistent but non-significant trend in iPSC-iNs.
“Interestingly, however, the gene sets that best characterized the dysregulation in AD iNs showed a consistent but unsignificant trend also in iPSC-iNs (Figure S5).”
Quote in the paperNot a substantial claim - Findingown data
PCA-based differentiation trajectory variance calculation defined a differentiation path on which AD iNs mapped more toward immature stages.
“Furthermore, principal-component analysis (PCA)-based differentiation trajectory variance calculation defined a differentiation path on which AD iNs mapped more toward immature stages (Figure S3).”
Quote in the paperSubstantial claim - Findingown data
Several key developmental and cancer-related transcription factors, such as Stat1/3, Klf4/9, Hif1α, FoxO1/3, Sox2, p53, nMyc, TEAD2, and Runx1, were consistently enriched in motif analysis of gained peaks.
“Interestingly, several key developmental and cancer-related transcription factors, such as Stat1/3, Klf4/9, Hif1α, FoxO1/3, Sox2, p53, nMyc, TEAD2, and Runx1, which are well known to directly induce the over-transcribed gene sets (Figure 4B), were consistently enriched (Figure 6F; Figure 4D).”
Quote in the paperSubstantial claim - Findingown data
DNA motif-binding factors with elevated activity in significantly differentially gained regions were enriched for signaling networks that control transcriptional misregulation in cancer, stem cells, malignant transformation signaling pathways, and senescence.
“DNA motif-binding factors with elevated activity in significantly differentially gained regions (Figure 6E) were enriched for signaling networks that control transcriptional misregulation in cancer, stem cells, malignant transformation signaling pathways, and senescence (Figures 6I and 6J; Figure S4; Table S6).”
Quote in the paperSubstantial claim - Findingown data
AD iNs showed increased levels of cyclin B1 immunoreactivity compared with controls.
“Indeed, immunocytochemistry revealed increased levels of cyclin B1 immunoreactivity in AD iNs compared with controls (Figures 5C and 5D).”
Quote in the paperSubstantial claim - Findingcitation
Compared with bulk adult brain region signatures from the Allen BrainSpan dataset, both iNs and iPSC-iNs are most similar to prefrontal and frontal adult human cortex samples and less similar to other regions.
“Consistently, compared with gene expression signatures from bulk adult brain regions from the Allen BrainSpan dataset, both iNs and iPSC-iNs were most similar to prefrontal and frontal adult human cortex samples and less to other regions (Figure 7E; Mertens et al., 2015a; Schafer et al., 2019).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Mertens et al., 2015a
Not checked in the free run.
- cites Schafer et al., 2019 source
Not checked in the free run.
- Findingown data
Peaks in proximity to promoters that are exclusively accessible in AD iNs were enriched for signaling and nervous system development genes.
“Peaks in proximity to promoters that are exclusively accessible in AD iNs were enriched for signaling and nervous system development genes (Figure S5).”
Quote in the paperNot a substantial claim - Findingown data
AD iNs do not display signs of accelerated epigenetic aging over control iNs.
“AD iNs did not display signs of accelerated epigenetic aging over control iNs (Figures 7I and 7J; Figure S6; Horvath, 2013; Huh et al., 2016).”
Quote in the paperSubstantial claim0 of 2 sources checked - Findingown data
No similarity differences between control and AD iNs are detected.
“Conversely, iNs displayed the highest similarity to the adult brain samples but not to pre-natal samples, and no similarity differences between control and AD iNs were detected (Figure 7L; Figure S6).”
Quote in the paperSubstantial claim - Findingcitation
iN DNA methylation ages reflect the adult and old chronological ages of their donors.
“Clearly, iN DNAm ages reflect the adult and old chronological ages of their donors, whereas pluripotent stem cells and their derivatives reflect pre-natal DNAm ages (Figure 7H; Huh et al., 2016; Kim et al., 2014; Lo Sardo et al., 2017).”
Quote in the paperSubstantial claim0 of 3 sources checked - Findingown data
RRHO mapping between pre-natal and adult brain and between iPSC-iNs and iNs reveals a pronounced bias in the overlap of iNs with adult brain samples.
“Consistently, rank-rank hypergeometric transcriptional overlap (RRHO) mapping between pre-natal and adult brain, and between iPSC-iNs and iNs, revealed a pronounced bias in the overlap of iNs with adult brain samples (Figure 7M; Plaisier et al., 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Plaisier et al., 2010 source
Not checked in the free run.
- Findingown data
Adult brain-specific splicing of MAPT and SCN2A is seen exclusively in iNs and adult brain, whereas iPSC-iNs predominantly express the fetal isoforms.
“In addition, adult brain-specific splicing of the microtubule-associated protein tau (MAPT) (Andreadis, 2005) and of the voltage-gated sodium channel gene SCN2A (Sanders et al., 2018) was seen exclusively in iNs and adult brain, whereas iPSC-iNs predominantly expressed the fetal isoforms (Figure S7).”
Quote in the paperSubstantial claim0 of 2 sources checked - Findingown data
Aging genes in iNs previously identified by RNA-seq from a healthy aging cohort do not show extended changes in AD iNs.
“Consistently, aging genes in iNs previously identified by RNA-seq from a healthy aging cohort did not show extended changes in AD iNs, and plotting AD iN DE genes across healthy aging iNs did not indicate their regulation by age; rather, a slightly inverse trend was detected (Figure 7J; Figure S6; Mertens et al., 2015a).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mertens et al., 2015a
Not checked in the free run.
- Findingown data
No major differences between control and AD iNs are noted in the PCA-based pre-natal versus adult variance dimension.
“Again, no major differences between control and AD iNs were noted, and the genes that contributed to the pre-natal versus adult variance were different from neuronal differentiation trajectory genes, indicating that AD-related neuronal fate instability does not challenge the overall adult identity of the cells to an extent that they would adopt fetal-like signatures (Figure S6).”
Quote in the paperSubstantial claim - Findingcitation
Pluripotent stem cells and their derivatives reflect pre-natal DNA methylation ages.
“Clearly, iN DNAm ages reflect the adult and old chronological ages of their donors, whereas pluripotent stem cells and their derivatives reflect pre-natal DNAm ages (Figure 7H; Huh et al., 2016; Kim et al., 2014; Lo Sardo et al., 2017).”
Quote in the paperSubstantial claim0 of 3 sources checked - Findingown data
Genes contributing to the pre-natal versus adult variance are different from neuronal differentiation trajectory genes.
“Again, no major differences between control and AD iNs were noted, and the genes that contributed to the pre-natal versus adult variance were different from neuronal differentiation trajectory genes, indicating that AD-related neuronal fate instability does not challenge the overall adult identity of the cells to an extent that they would adopt fetal-like signatures (Figure S6).”
Quote in the paperSubstantial claim - Findingcitation
Erasure of aging signatures and re-gaining of fetal identity represents a potent rescue in this study.
“Cellular aging features (Huh et al., 2016; Mertens et al., 2015a, 2018; Tang et al., 2017; Victor et al., 2014) and adult-like neuronal identity of iNs (Luo et al., 2019) are likely critical for the emergence of such phenotypes in sporadic AD neurons, because erasure of aging signatures and re-gaining of fetal identity represents a potent rescue in this study (Miller et al., 2013; Ocampo et al., 2”
Quote in the paperSubstantial claim0 of 2 sources checked - Findingown data
Only old iNs from AD patients show signatures of fate instability comparable with those of malignant transformation.
“However, only old iNs from AD patients showed signatures of fate instability comparable with those of malignant transformation.”
Quote in the paperSubstantial claim - Premisecitation
Fibroblast-derived iNs preserve substantial signatures of human aging, including transcriptomic, nuclear pore, mitochondrial, epigenetic, and other aspects of aging.
“Fibroblast-derived iNs preserve substantial signatures of human aging, including transcriptomic, nuclear pore, mitochondrial, epigenetic, and other aspects of aging (Herdy et al., 2019; Huh et al., 2016; Kim et al., 2018; Mertens et al., 2015a; Traxler et al., 2019).”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationown data
AD-related neuronal changes are age-dependent cellular programs that impair neuronal identity.
“Our findings identify AD-related neuronal changes as age-dependent cellular programs that impair neuronal identity.”
Quote in the paperSubstantial claim- Rests on an assumption: Aging is crucial for age-related neurodegenerative diseases to unfold.
- Premisecitation
iPSC neurons exhibit a fetal neuronal identity that might not be optimally suited to model all disease-relevant phenotypes.
“They are also known to exhibit a fetal neuronal identity that might not be optimally suited to model all disease-relevant phenotypes (Arbab et al., 2014; Luo et al., 2016; Patterson et al., 2012).”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationown data
Known characteristics of AD, including functional neuronal failure, stress response, and cell cycle re-entry, are reflected in AD iNs.
“These data indicate that known characteristics of AD, including functional neuronal failure, stress response, and cell cycle re-entry, are reflected in AD iNs.”
Quote in the paperSubstantial claim - Interpretationown data
A lack of fully differentiated neuronal transcription might underlie impaired neuronal functionality in AD iNs.
“Although it is commonly believed that neuronal changes in AD are the result of an accumulation of damaging agents, these data indicate that a lack of a fully differentiated neuronal transcription might underlie impaired neuronal functionality.”
Quote in the paperSubstantial claim - Interpretationown data
AD iNs regress toward an aberrantly de-differentiated state.
“These data suggest that AD iNs regress toward an aberrantly de-differentiated state.”
Quote in the paperSubstantial claim - Interpretationown data
Emergence of AD features in human cell culture models depends on age and adult-specific neuronal features.
“These data further support the view that features of AD relate to, but are distinct from, the features of normal aging, and their emergence in human cell culture models depends on age and adult-specific neuronal features.”
Quote in the paperSubstantial claim - Interpretationown data
Whole-transcriptome and epigenetic aging profiles of iNs more closely reflect adult human brain stages.
“Thus, whole-transcriptome and epigenetic aging profiles of iNs more closely reflect adult human brain stages, indicating that iNs are a useful model system to model age-dependent pathological mechanisms of sporadic AD.”
Quote in the paperSubstantial claim- Rests on an assumption: Transcriptome similarity between cultured neurons and BrainSpan cortical samples reflects their ontogenic (developmental) identity.
- Premisecitation
iPSC derivatives represent pre-natal brain stages.
“Because these data are consistent with the frequent observation that iPSC derivatives represent pre-natal brain stages (Luo et al., 2016; Stein et al., 2014), we asked if the ontogenic identity of iNs might better reflect adult stages.”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationown data
AD-related neuronal fate instability does not challenge the overall adult identity of the cells to an extent that they would adopt fetal-like signatures.
“Again, no major differences between control and AD iNs were noted, and the genes that contributed to the pre-natal versus adult variance were different from neuronal differentiation trajectory genes, indicating that AD-related neuronal fate instability does not challenge the overall adult identity of the cells to an extent that they would adopt fetal-like signatures (Figure S6).”
Quote in the paperSubstantial claim - Interpretationown data
iNs are a useful model system to model age-dependent pathological mechanisms of sporadic AD.
“Thus, whole-transcriptome and epigenetic aging profiles of iNs more closely reflect adult human brain stages, indicating that iNs are a useful model system to model age-dependent pathological mechanisms of sporadic AD.”
Quote in the paperSubstantial claim- Rests on an assumption: Transcriptome similarity between cultured neurons and BrainSpan cortical samples reflects their ontogenic (developmental) identity.
- Interpretationcitation
The changes we observed are likely a consequence of human neurons adhering to the principle that injury triggers cellular de-differentiation.
“Injury is a well-established trigger of cellular de-differentiation, and the changes we observed are likely a consequence of human neurons adhering to this principle (Gu et al., 2020; Jopling et al., 2010; Poplawski et al., 2020; Renthal et al., 2020; Tzahor and Poss, 2017; Wagner et al., 2017).”
Quote in the paperNot a substantial claim - Premisecitation
Neurons carrying aggressive familial AD mutations still show a similar phenotype when generated from iPSCs.
“However, neurons that carry aggressive familial AD mutations still show a similar phenotype when generated from iPSCs (Caldwell et al., 2020).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Caldwell et al., 2020 source
Not checked in the free run.
- Interpretationown data
Cellular aging features and adult-like neuronal identity of iNs are likely critical for the emergence of such phenotypes in sporadic AD neurons.
“Cellular aging features (Huh et al., 2016; Mertens et al., 2015a, 2018; Tang et al., 2017; Victor et al., 2014) and adult-like neuronal identity of iNs (Luo et al., 2019) are likely critical for the emergence of such phenotypes in sporadic AD neurons, because erasure of aging signatures and re-gaining of fetal identity represents a potent rescue in this study (Miller et al., 2013; Ocampo et al., 2”
Quote in the paperSubstantial claim0 of 3 sources checked
- May combine two claims. 40
- Classified as probably not a substantial claim. 13
May combine two claims.
Findingown dataAD patient-derived iNs exhibit strong neuronal transcriptome signatures characterized by downregulation of mature neuronal properties and upregulation of immature and progenitor-like signaling pathways.
“AD patient-derived iNs exhibit strong neuronal transcriptome signatures characterized by downregulation of mature neuronal properties and upregulation of immature and progenitor-like signaling pathways.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFibroblasts did not display any significant AD-specific DE genes, whereas 778 highly significant (FDR < 0.01) DE genes were identified in iNs.
“Unsurprisingly, fibroblasts did not display any significant AD-specific DE genes, whereas 778 highly significant (false discovery rate [FDR] < 0.01) DE genes were identified in iNs (Figure 2A; Table S3).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataGSEA of overlapping AD genes showed enrichment for mature neuronal categories such as synaptic transmission and oxidative phosphorylation (downregulated) and response to stress, regulation of cell proliferation, and pathways in cancer (upregulated).
“Gene set enrichment analysis (GSEA) of overlapping AD genes showed that they were enriched for mature neuronal categories such as synaptic transmission and oxidative phosphorylation (downregulated; Figure 2E) and response to stress, regulation of cell proliferation, and pathways in cancer (upregulated; Figure 2F).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataControl and AD iNs separated clearly by tSNE based on DE genes, confirming an AD-specific transcriptome signature that unified most patient iN samples, despite heterogeneity from four outlier samples.
“The validity of the DE genes was evidenced by a clear separation of control and AD iNs by t-distributed stochastic neighbor embedding (tSNE) that largely confirmed the presence of an AD-specific transcriptome signature that unified most patient iN samples, despite some heterogeneity driven by four outlier samples (Figure 2C).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAD iNs consistently showed the highest overlap with, and the best correlation to, neuronal cell-type-specific AD signatures from single-nucleus RNA-seq data.
“AD iNs consistently showed the highest overlap with, and the best correlation to, the neuronal cell-type-specific AD signatures (Figure 2H), with downregulated synapse-related and upregulated stress-related gene categories commonly visible in both systems (Figure 2I).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTop GO terms for upregulated AD iN genes identified overrepresentation of genes involved in cellular stress response, stem cell-related signal transduction, aging, and cell death competence; top KEGG pathways were related to cancer and senescence.
“The top significantly ranked Gene Ontology (GO) terms also identified an overrepresentation of genes involved in cellular stress response, stem cell-related signal transduction, aging, and cell death competence; the top significantly ranked Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were related to pathways involved in cancer and senescence (Figures 4B and 4C).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataiNs express both glutamatergic and GABAergic marker genes.
“Consistent with the immunocytochemistry and results from previous studies (Kim et al., 2018; Vadodaria et al., 2016), we detected expression of both glutamatergic and GABAergic marker genes in the iNs (Figure 1H).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataGene sets previously found downregulated in AD brains were typically also downregulated in AD iNs, and upregulated gene sets were also upregulated in AD iNs.
“Indeed, the gene sets that were previously found to be downregulated in AD brains were typically also downregulated in AD iNs, and upregulated gene sets were also upregulated in AD iNs (Figure 2D; Table S4).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataNgn2/Ascl1-based, small molecule-enhanced iN conversion and PSA-NCAM FACS isolation resulted in cultures of ∼90% βIII-tubulin-positive neuronal cells that readily expressed NeuN.
“Ngn2/Ascl1-based, small molecule-enhanced iN conversion and subsequent polysialylated neural cell adhesion molecule (PSA-NCAM) fluorescence-activated cell sorting (FACS) isolation resulted in cultures of ∼90% βIII-tubulin-positive neuronal cells that readily expressed NeuN (Figures 1C–1E).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataWithin the AD iN group, there were slightly more neurons with both lower and higher DNA content, with the increase of AD iNs over the diploid level being significant.
“Within the AD iN group, we observed slightly more neurons with both lower and higher DNA content, with the increase of AD iNs over the diploid level being significant (Figure S2), but we could not detect a completed neuronal DNA replication in iNs (Figures 5E and 5F; Figure S2).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAD iNs showed changes in DNA damage repair-related gene expression and increased numbers of nuclear H2A.X-positive foci.
“Indeed, AD iNs displayed increased levels of total ROS (Figure 5A), and we also detected changes in DNA damage repair-related gene expression and increased numbers of nuclear H2A.X-positive foci in AD iN nuclei (Figure S2).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataGenes both most upregulated during differentiation and decreased in AD iNs relate to synaptic functions, whereas genes downregulated during differentiation and increased in AD iNs hint toward changes in cell cycle control.
“The genes that are both the most upregulated during differentiation and also decreased in AD iNs relate to synaptic functions, whereas the genes that are downregulated during differentiation and increased in AD iNs hint toward changes in cell cycle control (Figure 4G).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataATAC-seq revealed a widespread increase in the number and width of open chromatin regions in AD iNs, which on average displayed 36% more peaks that were 7% wider.
“ATAC-seq revealed a widespread increase in the number and width of open chromatin regions in AD iNs, which on average displayed 36% more peaks that were 7% wider (Figures 6B and 6C).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataControl iNs showed a clear increase in similarity with progressive differentiation, whereas AD iNs showed little increase of similarity with progressive differentiation and higher similarity to immature stages.
“Control iNs showed a clear increase in similarity with progressive differentiation, whereas AD iNs showed little increase of similarity with progressive differentiation and higher similarity to immature stages (Figure 4F).”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Findingown dataCell cycle markers CCNB1 (cyclin B1) and CDK2 become silenced during neuronal differentiation.
“ROS and DNA damage can trigger neuronal aneuploidy and expression of cell cycle re-entry markers in AD brains (Mosch et al., 2007), and the cell cycle markers CCNB1 (cyclin B1) and CDK2 become silenced during neuronal differentiation (Figure 5B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataBoth iNs and iPSC-iNs show the highest transcriptome similarity to cortical excitatory neurons from single-cell RNA-seq data.
“Similar to iNs, iPSC-iN cultures contained vGlut1+ and GABA+ neurons and expressed marker genes for both subtypes, and both showed the highest similarity to cortical excitatory neurons from single-cell RNA-seq (scRNA-seq) data (Figure 7D; Figure S5; Mathys et al., 2019).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Mathys et al., 2019 source
Not checked in the free run.
May combine two claims.
Findingown dataDifferential peak analysis revealed 7,188 highly significantly differentially accessible peaks, 97% of which were gained in AD.
“Differential peak analysis revealed 7,188 highly significantly differentially accessible peaks, 97% of which were gained in AD (Figure 6E).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataiPSC-iN cultures contain vGlut1+ and GABA+ neurons and express marker genes for both subtypes.
“Similar to iNs, iPSC-iN cultures contained vGlut1+ and GABA+ neurons and expressed marker genes for both subtypes, and both showed the highest similarity to cortical excitatory neurons from single-cell RNA-seq (scRNA-seq) data (Figure 7D; Figure S5; Mathys et al., 2019).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
FindingcitationConversion of iPSCs to iPSC-iNs is highly efficient, with virtually all EGFP-positive iPSCs converting into neurons that predominantly express NeuN and vGlut1.
“As shown previously, conversion of iPSCs to iPSC-iNs is highly efficient, as virtually all EGFP-positive iPSCs convert into neurons that also predominantly express NeuN and vGlut1 (Figures S5; Schafer et al., 2019).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Schafer et al., 2019
Not checked in the free run.
May combine two claims.
Findingown dataiPSC-iNs show more gene expression differences than iPSCs or fibroblasts, but these differences do not reach statistical significance.
“iPSC-iNs showed more gene expression differences than iPSCs or fibroblasts, which did not reach statistical significance (Figure 7F).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataiPSC-iNs show relatively high transcriptome similarity to pre-natal brain samples but poor correlation with adult brain stages.
“As expected, we found that iPSC-iNs showed a relatively high degree of similarity with the transcriptomes of the pre-natal brain samples but exhibited relatively poor correlation with adult brain stages (Figure 7L; Figure S6).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPlotting AD iN DE genes across healthy aging iNs does not indicate their regulation by age; rather, a slightly inverse trend is detected.
“Consistently, aging genes in iNs previously identified by RNA-seq from a healthy aging cohort did not show extended changes in AD iNs, and plotting AD iN DE genes across healthy aging iNs did not indicate their regulation by age; rather, a slightly inverse trend was detected (Figure 7J; Figure S6; Mertens et al., 2015a).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mertens et al., 2015a
Not checked in the free run.
May combine two claims.
Findingown dataSingle-nucleus RNA-seq integration shows a similar pattern for excitatory and inhibitory neurons and indicates that adult transcriptome identity is encoded primarily within excitatory neuronal profiles.
“Integration of single-nucleus RNA-seq data showed a similar pattern for excitatory and inhibitory neurons and further indicated that adult transcriptome identity is encoded primarily within excitatory neuronal profiles (Figure S6).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAlong a PCA-based pre-natal versus adult variance dimension, iNs map close to adult brain samples, whereas iPSC-iNs map close to pre-natal samples.
“Furthermore, along a PCA-based pre-natal versus adult variance dimension, iNs also mapped close to adult brain samples, whereas iPSC-iNs mapped close to pre-natal samples (Figure S6).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataiNs display the highest transcriptome similarity to adult brain samples but not to pre-natal samples.
“Conversely, iNs displayed the highest similarity to the adult brain samples but not to pre-natal samples, and no similarity differences between control and AD iNs were detected (Figure 7L; Figure S6).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSporadic AD cases develop without clear genetic etiology and represent the vast majority of AD cases, with disease risk increasing exponentially with age.
“However, familial AD is comparatively rare, and sporadic AD cases that develop without clear genetic etiology represent the vast majority of cases, wherein disease risk increases exponentially with age (Querfurth and LaFerla, 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Querfurth and LaFerla, 2010 source
Not checked in the free run.
May combine two claims.
PremisecitationDirect conversion of human fibroblasts into iNs bypasses the embryo-like state and directly results in postmitotic neurons with mature marker expression and functionality.
“In contrast, direct conversion of human fibroblasts into induced neurons (iNs) bypasses the embryo-like state and directly results in postmitotic neurons with mature marker expression and functionality (Liu et al., 2013; Pang et al., 2011).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Liu et al., 2013 source
Not checked in the free run.
- cites Pang et al., 2011
Not checked in the free run.
May combine two claims.
PremisecitationReprogramming into pluripotency leaves old donor-derived iPSC-derived neurons with practically no traces of their donors' ages, and iPSC-associated cellular rejuvenation represents a major challenge when attempting to model age-dependent diseases.
“However, reprogramming into pluripotency leaves old, donor-derived iPSC-derived neurons with practically no traces of their donors’ ages, and iPSC-associated cellular rejuvenation represents a major challenge when attempting to model age-dependent diseases (Böhnke et al., 2018; Kang et al., 2016; Mertens et al., 2015a; Miller et al., 2013; Tang et al., 2017).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Böhnke et al., 2018
Not checked in the free run.
- cites Kang et al., 2016
Not checked in the free run.
- cites Mertens et al., 2015a
Not checked in the free run.
May combine two claims.
Study design and conductown dataGene expression differences between control and AD groups largely aligned with clinical diagnosis, whereas other classifiers did not appear to bias the detected DE genes.
“Gene expression differences between the groups largely aligned with clinical diagnosis, whereas other classifiers did not appear to bias the detected DE genes (Figure 2B).”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe hypo-mature state of AD iNs partially resembles both malignant transformation-like signatures and immature neuronal stages.
“This hypo-mature state partially resembles both malignant transformation-like signatures and immature neuronal stages.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataAD iNs gained accessibility at normally silenced LDHA promoter regions, where gained accessibility leads to leaky expression and thus promotion of an immature neuronal state, stem cell- and cancer-associated signaling pathways, and precursor-like metabolic properties.
“Furthermore, the chromatin landscape signatures at key genes such as LDHA showed that AD iNs gained accessibility at normally silenced promoter regions, where gained accessibility leads to leaky expression and thus promotion of an immature neuronal state, stem cell- and cancer-associated signaling pathways, and precursor-like metabolic properties (Figure 6G).”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataAD iN-specific chromatin landscape changes accommodate a persistent lack of a differentiated identity and suggest that epigenetic changes might underlie the transcriptional and functional lack of the differentiated state in AD neurons.
“Overall, the AD iN-specific chromatin landscape changes accommodate a persistent lack of a differentiated identity and suggest that epigenetic changes might underlie the transcriptional and functional lack of the differentiated state in AD neurons.”
Quote in the paperSubstantial claim- Rests on an assumption: Stem and progenitor cells, as well as transformed cells, typically reflect a globally open chromatin state, whereas differentiated cells possess a more defined and closed chromatin landscape.
May combine two claims.
Interpretationown dataAD iNs successfully completed iN conversion but showed a lack of mature neuronal identity gene expression.
“AD iNs thus successfully completed iN conversion but showed a lack of mature neuronal identity gene expression.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataAD iNs show signs of elevated ROS, DNA damage, and aneuploid DNA contents, which may trigger neuronal de-differentiation and lead to an aberrant hypo-mature cellular state that partially mirrors a stem/progenitor-associated transcriptional program and expression of non-neuronal proteins.
“Thus, AD iNs show signs of elevated ROS, DNA damage, and aneuploid DNA contents, which may trigger neuronal de-differentiation and lead to an aberrant hypo-mature cellular state that partially mirrors a stem/progenitor-associated transcriptional program and expression of non-neuronal proteins, including markers of cell cycle and non-neuronal energy metabolism.”
Quote in the paperSubstantial claim- Rests on an assumption: LDHA is inversely associated with mature neuronal identity.
May combine two claims.
Study design and conductown dataBoth control and AD iNs showed equally increasing similarity paralleling progressive iN conversion, and they exhibited equivalent conversion efficiencies, loss of fibroblast signatures, and iN identity marked by NeuN.
“Both control and AD iNs showed an equally increasing similarity, paralleling progressive iN conversion, and they exhibited equivalent conversion efficiencies, loss of fibroblast signatures, and iN identity marked by NeuN (Figures 1D and 1E; Figures S1 and S3).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationErosion of epigenetic control, transcriptional drift, and the incidence of malignant transformation are strongly associated with human aging.
“Erosion of epigenetic control and transcriptional drift and the incidence of malignant transformation are strongly associated with human aging (Veitia et al., 2017; Zheng et al., 2016a).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Veitia et al., 2017
Not checked in the free run.
- cites Zheng et al., 2016a
Not checked in the free run.
May combine two claims.
PremisecitationNeuronal de-differentiation, loss of mature neuronal fate, and markers suggesting re-entry of neurons into the cell cycle are pathological hallmarks of AD.
“Neuronal de-differentiation, loss of mature neuronal fate, and markers that suggest a re-entry of neurons into the cell cycle are pathological hallmarks of AD (Arendt, 2012; Arendt et al., 2000; Busser et al., 1998; Currais et al., 2009; Herrup and Yang, 2007; McShea et al., 1999; Nagy et al., 1997; Yang et al., 2001).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Arendt, 2012
Not checked in the free run.
- cites Arendt et al., 2000
Not checked in the free run.
- cites Busser et al., 1998
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOutside the nervous system, epigenetic erosion and loss of cell identity are established key features of aging.
“Outside of the nervous system, epigenetic erosion and loss of cell identity are established key features of aging (Ma et al., 2018; Teschendorff et al., 2013; Veitia et al., 2017; Wang et al., 2008; Zheng et al., 2016a).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Ma et al., 2018
Not checked in the free run.
- cites Teschendorff et al., 2013
Not checked in the free run.
- cites Veitia et al., 2017
Not checked in the free run.
May combine two claims.
InterpretationcitationOur data are consistent with the observation that oxidative stress and DNA damage can induce cell cycle re-entry markers of neurons, leading to neuronal hypo-maturity and functional defects.
“Our data are consistent with the observation that oxidative stress and DNA damage can induce cell cycle re-entry markers of neurons (Walton et al., 2019; Yang et al., 2001), leading to neuronal hypo-maturity and functional defects (Kruman et al., 2004; Sharma et al., 2017), that might further lead to metabolic reprogramming, activation of cell death competence (Benn and Woolf, 2004; Kole et al., 2”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Walton et al., 2019
Not checked in the free run.
- cites Yang et al., 2001
Not checked in the free run.
- cites Kruman et al., 2004
Not checked in the free run.
May combine two claims.
Interpretationown dataFeatures of AD relate to, but are distinct from, features of normal aging.
“These data further support the view that features of AD relate to, but are distinct from, the features of normal aging, and their emergence in human cell culture models depends on age and adult-specific neuronal features.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenSubjects were followed for at least 2 years after biopsy with no evidence of cognitive decline in controls and with evidence of progressive impairment in AD.
“They were followed for at least 2 years after biopsy with no evidence of cognitive decline (controls) and with evidence of progressive impairment (AD).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationInjury is a well-established trigger of cellular de-differentiation.
“Injury is a well-established trigger of cellular de-differentiation, and the changes we observed are likely a consequence of human neurons adhering to this principle (Gu et al., 2020; Jopling et al., 2010; Poplawski et al., 2020; Renthal et al., 2020; Tzahor and Poss, 2017; Wagner et al., 2017).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
InterpretationcitationFor studying age-related vulnerability and mechanisms relevant to AD, iNs have advantages over iPSC models and complement isogenic iPSC strategies.
“Collectively, for studying age-related vulnerability and mechanisms relevant to AD, iNs have advantages over iPSC models and thus complement isogenic iPSC strategies (van der Kant et al., 2019; Meyer et al., 2019; Woodruff et al., 2013).”
Quote in the paperSubstantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll data for one experiment were acquired from cells cultured and processed in parallel on the same microscope with the exact same setting.
“All data for one experiment were acquired from cells cultured and processed in parallel on the same microscope with the exact same setting used.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenStatistical values were corrected for false discovery rates using the Benjamini-Hochberg method.
“Statistical values were corrected for false discovery rates (FDR) using the Benjamini-Hochberg method implemented in R.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPrevious studies on Huntington's disease have consistently detected signs of neuronal epigenetic instability.
“Previous studies on Huntington’s disease have consistently detected signs of neuronal epigenetic instability (Ayata et al., 2018; von Schimmelmann et al., 2016).”
Quote in the paperNot a substantial claim0 of 2 sources checkedClassified as probably not a substantial claim. May combine two claims.
Study design and conductown dataBoth AD and control subjects underwent rigorous clinical assessment including detailed neuropsychological testing and brain imaging, and subjects selected for biopsies were stratified to show either a clear non-demented clinical picture or a clear phenotype of AD.
“Both AD and control subjects underwent rigorous clinical assessment as part of the ADRC study, including detailed neuropsychological testing and brain imaging (MRI), and the subjects selected for biopsies were stratified to show either a clear non-demented clinical picture or clear phenotype of AD (classified as probable AD until pathological confirmation).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe 'skin and blood clock' best predicts chronological ages of cell culture samples.
“the ‘in vitro clock,’ also known as the ‘skin and blood clock,’ was used as it best predicts chronological ages of cell culture samples (Horvath et al., 2019).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Horvath et al., 2019
Not checked in the free run.
The paper relies on this without support.
Aging is crucial for age-related neurodegenerative diseases to unfold.
“Because aging is likely crucial for age-related neurodegenerative diseases to unfold, we generated age-equivalent fibroblast-derived iNs from a cohort of primarily sporadic AD patients and cognitively normal controls.”
The paper relies on this without support.
Stem and progenitor cells, as well as transformed cells, typically reflect a globally open chromatin state, whereas differentiated cells possess a more defined and closed chromatin landscape.
“Stem and progenitor cells, as well as transformed cells, typically reflect a globally open chromatin state, whereas differentiated cells possess a more defined and closed chromatin landscape (Figure 6A).”
The paper relies on this without support.
LDHA is inversely associated with mature neuronal identity.
“We assessed lactate dehydrogenase A (LDHA), a canonical glycolysis gene that is inversely associated with mature neuronal identity and is downregulated during neuronal differentiation (Figure 5G).”
The paper relies on this without support.
Transcriptome similarity between cultured neurons and BrainSpan cortical samples reflects their ontogenic (developmental) identity.
“To classify the iNs and iPSC-iNs on an ontogenic identity scale, we compared our transcriptome data with samples from the entire range of human cortical brain development (Figure 7K).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Neurons directly induced from individuals with AD through NGN2/ASCL1 overexpression exhibited age-associated dysregulations such as instability of mature neuronal fate, increased cellular senescence, and metabolic shifts.
“These neurons exhibited several age-associated dysregulations such as instability of mature neuronal fate, increased cellular senescence, and metabolic shifts (11, 24, 25)”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [11]
The Results sections on direct iN conversion and stress-related de-differentiation report Ngn2/Ascl1 conversion of AD patient fibroblasts, loss of mature neuronal identity, and changes in genes associated with energy metabolism. The Results section on immature transcriptional programs finds enrichment of senescence-related pathways, but does not establish increased cellular senescence in the neurons themselves; the epigenetic-aging analysis also reports no accelerated aging relative to controls. Page numbers are unavailable in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measuredNo AD hallmark neuropathology was shown in neurons directly induced from individuals with AD through NGN2/ASCL1 overexpression.
“but no AD hallmark neuropathology was shown.”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [11]
The Results section, “Direct iN conversion of fibroblasts from AD patients and controls” (page unavailable), confirms that the authors generated neurons from AD donors using Ngn2/Ascl1. But it also reports an increased Aβ42/40 ratio in neurons from familial AD patients, so the unqualified statement that no AD hallmark pathology was shown overstates the findings. The cited passages do not establish the absence of other hallmark neuropathology. (LLM, conf=0.78)
Experimental — accuracy not yet measuredRecent studies have directly induced neurons from individuals with AD through NGN2/ASCL1 overexpression.
“Recent studies have directly induced neurons from individuals with AD through NGN2/ASCL1 overexpression.”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [11]
Increased ROS and DSBs are documented in neurons derived from sporadic AD patient fibroblasts, indicating that age-dependent features of genomic instability are recapitulated in human in vitro models of disease.
“More recently, increased ROS and DSBs have also been documented in neurons derived directly from sporadic AD patient fibroblasts, indicating that age‐dependent features of genomic instability are recapitulated in human in vitro models of disease (Mertens et al, 2021).”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Mertens et al, 2021
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Addgene identifiers conflict between resource sections
MinorThe key resources table assigns #127289 to the Ascl1 construct and #84777 to the EGFP construct. Materials availability instead assigns #127288 to Ascl1 and #127289 to EGFP.
“| pLVXUbC-rtTA-Ngn2:2A:Ascl1 | (Herdy et al., 2019) | Addgene #127289 | | pLVXUbC-rtTA-Ngn2:2A:EGFP | (Schafer et al., 2019) | Addgene #84777 |”
“Direct conversion lentiviral plasmids have been deposited to Addgene #127288 (pLVX-UbC-rtTA-Ngn2:2A:Ascl1) and #127289 (pLVX-UbC-rtTA-Ngn2:2A:EGFP).”
Calcium-imaging cell counts exceed the stated sampling plan
MinorThe methods specify 10 donors, three fields per donor, and 10 cells per field, which gives 300 cells total, or 150 per group given the five donors per group in the caption. Figure 3 instead reports 160 control cells and 184 AD cells.
“(I) Ca2+ event number in control (n = 160 cells; five donors) and AD neurons (n = 184 cells; five donors).”
“Control and AD iNs (n = 10) were assessed with 3 fields recorded for each donor. We analyzed 10 cells per field that were hSyn-dsRed+ and exhibited neuron morphologies.”
Mature-neuron results point to incompatible Figure 4 panels
MinorThe text cites Figures 4C and 4D for downregulated mature-neuronal gene sets and markers. The Figure 4 caption identifies those panels as upregulated KEGG pathways and dysregulated gene sets; Figure 3C and 3D are captioned as the mature-neuronal results.
“Then we tested representative, previously defined mature neuronal gene sets and corresponding marker genes, including synaptic plasticity and NRFS/REST targets, that were markedly downregulated in AD iNs (Figures 4C and 4D; Kim et al., 2015; Satoh et al., 2013).”
“(C) Violin plot showing expression changes in control versus AD iNs of published gene sets that represent mature neuronal identity. Significance values for each gene set are based on comparison with fibroblast and iPSC-iNs from the same cohort (Figures S5H and S5I). (D) Bar graphs showing fold changes and significance of downregulated mature neuronal marker genes in AD versus control iNs.”
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221 · see citing works
DNA methylation age of human tissues and cell types
Horvath, S. (2013) · Genome Biology · doi:10.1186/gb-2013-14-10-r115 · Cited by 7,075 · see citing works
Self-citationBuenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y., & Greenleaf, W. J. (2013) · Nature Methods · doi:10.1038/nmeth.2688 · Cited by 6,422 · see citing works
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069 · see citing works
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569 · see citing works
Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125 · see citing works
Single-cell transcriptomic analysis of Alzheimer’s disease
Mathys, H., Davila-Velderrain, J., Peng, Z., Gao, F., Mohammadi, S., Young, J. Z., Menon, M., He, L., Abdurrob, F., Jiang, X., et al. (2019) · Nature · doi:10.1038/s41586-019-1195-2 · Cited by 2,568 · see citing works
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
Bild, A., Yao, G., Chang, J. T., Wang, Q., Potti, A., Chasse, D. A. D., Joshi, M.-B., Harpole, D. H., Lancaster, J. M., Berchuck, A., et al. (2005) · Nature · doi:10.1038/nature04296 · Cited by 1,992 · see citing works
The Cellular Phase of Alzheimer’s Disease
De Strooper, B., & Karran, E. (2016) · Cell · doi:10.1016/j.cell.2015.12.056 · Cited by 1,990 · see citing works
2015 Alzheimer's disease facts and figures
Alzheimer's Association (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.02.003 · Cited by 1,673 · see citing works
Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease
Ittner, L. M., & Götz, J. (2010) · Nature reviews. Neuroscience · doi:10.1038/nrn2967 · Cited by 1,422 · see citing works
The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells
Cordenonsi, M., Zanconato, F., Azzolin, L., Forcato, M., Rosato, A., Frasson, C., Inui, M., Montagner, M., Parenti, A. R., Poletti, A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.048 · Cited by 1,381 · see citing works
Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation
Jopling, C., Sleep, E., Raya, M., Martí, M., Raya, A., & Belmonte, J. C. I. (2010) · Nature · doi:10.1038/nature08899 · Cited by 1,333 · see citing works
Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells
Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., Hefferan, M. P., Van Gorp, S., Nazor, K. L., Boscolo, F. S., et al. (2012) · Nature · doi:10.1038/nature10821 · Cited by 1,253 · see citing works
Self-citationInduction of human neuronal cells by defined transcription factors
Pang, Z. P., Yang, N., Vierbuchen, T., Ostermeier, A., Fuentes, D., Yang, T. Q., Citri, A., Sebastiano, V., Marro, S. G., Südhof, T. C., et al. (2011) · Nature · doi:10.1038/nature10202 · Cited by 1,249 · see citing works
Ageing and neuronal vulnerability
Mattson, M. P., & Magnus, T. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1886 · Cited by 1,075 · see citing works
In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.
Ocampo, A., Reddy, P., Martinez-Redondo, P., Platero-Luengo, A., Hatanaka, F., Hishida, T., Li, M., Lam, D., Kurita, M., Beyret, E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.052 · Cited by 988 · see citing works
Grubman, A., Chew, G., Ouyang, J. F., Sun, G., Choo, X. Y., McLean, C., Simmons, R. K., Buckberry, S., Vargas-Landin, D. B., Poppe, D., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0539-4 · Cited by 956 · see citing works
Axon degeneration mechanisms: Commonality amid diversity
Coleman, M. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1788 · Cited by 819 · see citing works
Horvath, S., Oshima, J., Martin, G. M., Lu, A. T., Quach, A., Cohen, H., Felton, S., Matsuyama, M., Lowe, D., Kabacik, S., et al. (2018) · Aging · doi:10.18632/aging.101508 · Cited by 815 · see citing works
Self-citationREST and Stress Resistance in Aging and Alzheimer’s Disease
Lu, T., Aron, L., Zullo, J., Pan, Y., Kim, H., Chen, Y., Yang, T.-H., Kim, H.-M., Drake, D., Liu, X., et al. (2014) · Nature · doi:10.1038/nature13163 · Cited by 789 · see citing works
Human iPSC-based modeling of late-onset disease via progerin-induced aging
Miller, J. D., Ganat, Y. M., Kishinevsky, S., Bowman, R. L., Liu, B., Tu, E. Y., Mandal, P. K., Vera, E., Shim, J.-W., Kriks, S., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.11.006 · Cited by 777 · see citing works
Mertens, J., Paquola, A. C. M., Ku, M., Hatch, E., Böhnke, L., Ladjevardi, S., McGrath, S., Campbell, B., Lee, H., Herdy, J. R., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.09.001 · Cited by 765 · see citing works
Self-citationZheng, X., Boyer, L., Jin, M., Mertens, J., Kim, Y., Ma, L., Ma, L., Hamm, M., Gage, F. H., & Hunter, T. (2016) · eLife · doi:10.7554/elife.13374 · Cited by 671 · see citing works
Self-citationLombardo, I., Ramaswamy, G., Piscitelli, S. C., & Friedhoff, L. T. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.08.154 · Cited by 656 · see citing works
DNA Replication Precedes Neuronal Cell Death in Alzheimer's Disease
Yang, Y., Geldmacher, D., & Herrup, K. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02661.2001 · Cited by 607 · see citing works
Blalock, E. M., Chen, K.-C., Sharrow, K., Herman, J. P., Porter, N. M., Foster, T. C., & Landfield, P. W. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-09-03807.2003 · Cited by 570 · see citing works
Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder
Study, T. P. O. B. D., Mertens, J., Wang, Q.-W., Kim, Y., Yu, D. X., Pham, S., Yang, B., Zheng, Y., Diffenderfer, K. E., Zhang, J., et al. (2015) · Nature · doi:10.1038/nature15526 · Cited by 562 · see citing works
Self-citationTranscriptional Reprogramming of Distinct Peripheral Sensory Neuron Subtypes after Axonal Injury
Renthal, W. R., Tochitsky, I., Yang, L., Cheng, Y., Li, E., Kawaguchi, R., Geschwind, D. H., & Woolf, C. J. (2020) · Neuron · doi:10.1016/j.neuron.2020.07.026 · Cited by 544 · see citing works
Ectopic Cell Cycle Proteins Predict the Sites of Neuronal Cell Death in Alzheimer’s Disease Brain
Busser, J., Geldmacher, D. S., & Herrup, K. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-08-02801.1998 · Cited by 543 · see citing works
Hutchinson, E. (2011) · Nature reviews. Neuroscience · doi:10.1038/nrn2985 · Cited by 534 · see citing works
Targeting Cancer Stemness in the Clinic: From Hype to Hope
Saygin, C., Matei, D., Majeti, R., Reizes, O., & Lathia, J. D. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2018.11.017 · Cited by 517 · see citing works
Cell cycle regulation in the postmitotic neuron: oxymoron or new biology?
Herrup, K., & Yang, Y. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2124 · Cited by 507 · see citing works
Plaisier, S. B., Taschereau, R., Wong, J. A., & Graeber, T. G. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq636 · Cited by 468 · see citing works
Age-Specific Epigenetic Drift in Late-Onset Alzheimer's Disease
Wang, S.-C., Oelze, B., & Schumacher, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002698 · Cited by 467 · see citing works
Epigenetic regulation of brain region-specific microglia clearance activity
Ayata, P., Badimon, A., Strasburger, H. J., Duff, M. K., Montgomery, S. E., Loh, Y.-H. E., Ebert, A., Pimenova, A. A., Ramirez, B. R., Chan, A. T., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0192-3 · Cited by 460 · see citing works
Allen, M., Carrasquillo, M. M., Funk, C., Heavner, B. D., Zou, F., Younkin, C. S., Burgess, J. D., Chai, H.-S., Crook, J., Eddy, J. A., et al. (2016) · Scientific Data · doi:10.1038/sdata.2016.89 · Cited by 439 · see citing works
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain
Luo, C., Lancaster, M. A., Castanon, R., Nery, J. R., Knoblich, J. A., & Ecker, J. R. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.12.001 · Cited by 370 · see citing works
Adult cell plasticity in vivo: de-differentiation and transdifferentiation are back in style
Merrell, A. J., & Stanger, B. Z. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.24 · Cited by 369 · see citing works
Cell Cycle Activation Linked to Neuronal Cell Death Initiated by DNA Damage
Kruman, I. I., Wersto, R. P., Cardozo‐Pelaez, F., Smilenov, L. B., Chan, S. L., Chrest, F. J., Emokpae, R., Gorospe, M., & Mattson, M. P. (2004) · Neuron · doi:10.1016/s0896-6273(04)00017-0 · Cited by 365 · see citing works
van der Kant, R., Langness, V. F., Herrera, C. M., Williams, D. A., Fong, L. K., Leestemaker, Y., Steenvoorden, E., Rynearson, K. D., Brouwers, J. F., Helms, J. B., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2018.12.013 · Cited by 350 · see citing works
Self-citationCardiac regeneration strategies: Staying young at heart
Tzahor, E., & Poss, K. D. (2017) · Science · doi:10.1126/science.aam5894 · Cited by 349 · see citing works
Liu, M.-L., Zang, T., Zou, Y., Chang, J. C., Gibson, J. R., Huber, K. M., & Zhang, C.-L. (2013) · Nature Communications · doi:10.1038/ncomms3183 · Cited by 343 · see citing works
Progress in Understanding and Treating SCN2A-Mediated Disorders
Sanders, S. J., Campbell, A. J., Cottrell, J. R., Moller, R. S., Wagner, F. F., Auldridge, A. L., Bernier, R. A., Catterall, W. A., Chung, W. K., Empfield, J. R., et al. (2018) · Trends in Neurosciences · doi:10.1016/j.tins.2018.03.011 · Cited by 338 · see citing works
Targeting the NF-κB signaling pathway in Notch1-induced T-cell leukemia
Vilimas, T., Mascarenhas, J., Palomero, T., Mandal, M., Buonamici, S., Meng, F., Thompson, B. J., Spaulding, C., Macaroun, S., Alegre, M., et al. (2006) · Nature Medicine · doi:10.1038/nm1524 · Cited by 335 · see citing works
Cell cycle markers in the hippocampus in Alzheimer's disease
Nagy, Z., Esiri, M. M., Cato, A.-M., & Smith, A. D. (1997) · Acta Neuropathologica · doi:10.1007/s004010050665 · Cited by 318 · see citing works
Age-associated epigenetic drift: implications, and a case of epigenetic thrift?
Teschendorff, A. E., West, J., & Beck, S. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt375 · Cited by 318 · see citing works
Small molecules enable highly efficient neuronal conversion of human fibroblasts.
Ladewig, J., Mertens, J., Kesavan, J., Doerr, J., Poppe, D., Glaue, F., Herms, S., Wernet, P., Kögler, G., Müller, F.-J., et al. (2012) · Nature Methods · doi:10.1038/nmeth.1972 · Cited by 316 · see citing works
Self-citationAlzheimer's disease: synapses gone cold
Koffie, R. M., Hyman, B. T., & Spires‐Jones, T. L. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-63 · Cited by 315 · see citing works
Andreadis, A. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.08.010 · Cited by 311 · see citing works
Generation of Human Striatal Neurons by MicroRNA-Dependent Direct Conversion of Fibroblasts
Victor, M. B., Richner, M., Hermanstyne, T. O., Ransdell, J. L., Sobieski, C., Deng, P.-Y., Klyachko, V. A., Nerbonne, J. M., & Yoo, A. S. (2014) · Neuron · doi:10.1016/j.neuron.2014.10.016 · Cited by 295 · see citing works
Schafer, S. T., Paquola, A. C. M., Stern, S., Gosselin, D., Ku, M., Pena, M., Kuret, T. J. M., Liyanage, M., Mansour, A. A., Jaeger, B. N., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0295-x · Cited by 288 · see citing works
Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease
Wu, Z., Guo, H., Chow, N., Sallstrom, J., Bell, R. D., Deane, R., Brooks, A. I., Kanagala, S., Rubio, A., Sagare, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1287 · Cited by 280 · see citing works
Aneuploidy and DNA Replication in the Normal Human Brain and Alzheimer's Disease
Mosch, B., Morawski, M., Mittag, A., Lenz, D., Tárnok, A., & Arendt, T. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0379-07.2007 · Cited by 271 · see citing works
Moehlmann, T., Winkler, E., Xia, X., Edbauer, D., Murrell, J. R., Capell, A., Kaether, C., Zheng, H., Ghetti, B. F., Haass, C., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112686799 · Cited by 264 · see citing works
Mertens, J., Reid, D. A., Lau, S., Kim, Y., & Gage, F. H. (2018) · Annual Review of Genetics · doi:10.1146/annurev-genet-120417-031534 · Cited by 252 · see citing works
Self-citationInjured adult neurons regress to an embryonic transcriptional growth state
Poplawski, G. H. D., Kawaguchi, R., Van Niekerk, E., Lu, P., Mehta, N., Canete, P., Lie, R., Dragatsis, I., Meves, J. M., Zheng, B., et al. (2020) · Nature · doi:10.1038/s41586-020-2200-5 · Cited by 247 · see citing works
Adult neuron survival strategies — slamming on the brakes
Benn, S. C., & Woolf, C. J. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1477 · Cited by 246 · see citing works
Polycomb repressive complex 2 (PRC2) silences genes responsible for neurodegeneration
von Schimmelmann, M., Feinberg, P. A., Sullivan, J. M., Ku, S. M., Badimon, A., Duff, M. K., Wang, Z., Lachmann, A., Dewell, S., Ma'ayan, A., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4360 · Cited by 225 · see citing works
Influence of donor age on induced pluripotent stem cells
Lo Sardo, V., Ferguson, W., Erikson, G. A., Topol, E. J., Baldwin, K. K., & Torkamani, A. (2017) · Nature Biotechnology · doi:10.1038/nbt.3749 · Cited by 223 · see citing works
Age-Related Accumulation of Somatic Mitochondrial DNA Mutations in Adult-Derived Human iPSCs
Kang, E., Wang, X., Tippner-Hedges, R., Ma, H., Folmes, C. D. L., Gutiérrez, N. M., Lee, Y., Dyken, C. V., Ahmed, R., Li, Y., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.02.005 · Cited by 216 · see citing works
REST and neural gene network dysregulation in iPSC models of Alzheimer’s disease
Meyer, K., Feldman, H. M., Lu, T., Drake, D., Lim, E. T., Ling, K.-H., Bishop, N. A., Pan, Y., Seo, J., Lin, Y.-T., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.023 · Cited by 216 · see citing works
Maintenance of age in human neurons generated by microRNA-based neuronal conversion of fibroblasts
Huh, C. J., Zhang, B., Victor, M. B., Dahiya, S., Batista, L. F., Horvath, S., & Yoo, A. S. (2016) · eLife · doi:10.7554/elife.18648 · Cited by 213 · see citing works
Self-citationBlalock, E. M., Buechel, H. M., Popovic, J., Geddes, J. W., & Landfield, P. W. (2011) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2011.06.007 · Cited by 211 · see citing works
Altered Proteins in the Aging Brain
Elobeid, A., Libard, S., Leino, M., Popova, S. N., & Alafuzoff, I. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw002 · Cited by 202 · see citing works
A Quantitative Framework to Evaluate Modeling of Cortical Development by Neural Stem Cells
Stein, J. L., de la Torre-Ubieta, L., Tian, Y., Parikshak, N. N., Hernández, I. A., Marchetto, M. C., Baker, D. K., Lu, D., Hinman, C. R., Lowe, J. K., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.035 · Cited by 201 · see citing works
Self-citationHistone variant H2A.J accumulates in senescent cells and promotes inflammatory gene expression
Contrepois, K., Coudereau, C., Benayoun, B. A., Schuler, N., Roux, P.-F., Bischof, O., Courbeyrette, R., Carvalho, C., Thuret, J.-Y., Ma, Z., et al. (2017) · Nature Communications · doi:10.1038/ncomms14995 · Cited by 191 · see citing works
When loss is gain: reduced presenilin proteolytic function leads to increased Aβ42/Aβ40
Wolfe, M. S. (2007) · EMBO Reports · doi:10.1038/sj.embor.7400896 · Cited by 190 · see citing works
Young, J. E., Boulanger-Weill, J., Williams, D. A., Woodruff, G., Buen, F., Revilla, A. C., Herrera, C. M., Israel, M. A., Yuan, S. H., Edland, S. D., et al. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.02.004 · Cited by 181 · see citing works
Self-citationMature neurons: equipped for survival
Kole, A. J., Annis, R. P., & Deshmukh, M. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.220 · Cited by 180 · see citing works
Loss of SATB1 Induces p21-Dependent Cellular Senescence in Post-mitotic Dopaminergic Neurons
Riessland, M., Kolisnyk, B., Kim, T. W., Cheng, J., Ni, J., Pearson, J. A., Park, E. J., Dam, K., Acehan, D., Ramos-Espiritu, L. S., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.08.013 · Cited by 180 · see citing works
Woodruff, G., Young, J. E., Martinez, F. J., Buen, F., Gore, A., Kinaga, J., Li, Z., Yuan, S. H., Zhang, K., & Goldstein, L. S. B. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.018 · Cited by 177 · see citing works
Self-citationChow, H.-M., Shi, M., Cheng, A., Gao, Y., Chen, G., Song, X., So, R. W. L., Zhang, J., & Herrup, K. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0505-1 · Cited by 171 · see citing works
Tang, Y., Liu, M.-L., Zang, T., & Zhang, C. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00359 · Cited by 163 · see citing works
Alzheimer's disease: The right drug, the right time
Golde, T. E., DeKosky, S. T., & Galasko, D. (2018) · Science · doi:10.1126/science.aau0437 · Cited by 146 · see citing works
Self-citationDefining the nature of human pluripotent stem cell progeny
Patterson, M., Chan, D. N., Ha, I., Case, D., Cui, Y., Handel, B. V., Mikkola, H. K., & Lowry, W. E. (2012) · Cell Research · doi:10.1038/cr.2011.133 · Cited by 145 · see citing works
Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer disease
McShea, A., Wahl, A. F., & Smith, M. A. (1999) · Medical Hypotheses · doi:10.1054/mehy.1997.0680 · Cited by 140 · see citing works
Cell Cycle Activation and Aneuploid Neurons in Alzheimer's Disease
Arendt, T. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8262-0 · Cited by 133 · see citing works
Generation of functional human serotonergic neurons from fibroblasts
Vadodaria, K. C., Mertens, J., Paquola, A. C. M., Bardy, C., Li, X., Jappelli, R., Fung, L., Marchetto, M. C., Hamm, M., Gorris, M. A. J., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.161 · Cited by 132 · see citing works
Self-citationEpigenetic drift of H3K27me3 in aging links glycolysis to healthy longevity in Drosophila
Ma, Z., Wang, H., Cai, Y. A., Wang, H., Niu, K., Wu, X., Ma, H., Yang, Y., Tong, W., Liu, F., et al. (2018) · eLife · doi:10.7554/elife.35368 · Cited by 132 · see citing works
Annese, A., Manzari, C., Lionetti, C., Picardi, E., Horner, D. S., Chiara, M., Caratozzolo, M. F., Tullo, A., Fosso, B., Pesole, G., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22701-2 · Cited by 125 · see citing works
Epigenetic Drift, Epigenetic Clocks and Cancer Risk
Zheng, S., Widschwendter, M., & Teschendorff, A. E. (2016) · Epigenomics · doi:10.2217/epi-2015-0017 · Cited by 118 · see citing works
Kim, Y., Zheng, X., Ansari, Z., Bunnell, M. C., Herdy, J. R., Traxler, L., Lee, H., Paquola, A. C. M., Blithikioti, C., Ku, M., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.105 · Cited by 117 · see citing works
Self-citationKoch, P., Tamboli, I. Y., Mertens, J., Wunderlich, P., Ladewig, J., Stüber, K., Esselmann, H., Wiltfang, J., Brüstle, O., & Walter, J. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.02.012 · Cited by 110 · see citing works
Self-citationThe neuronal cell cycle as a mechanism of pathogenesis in Alzheimer's disease
Currais, A., Hortobágyi, T., & Soriano, S. (2009) · Aging · doi:10.18632/aging.100045 · Cited by 101 · see citing works
Kim, M., Park, Y.-K., Kang, T.-W., Lee, S.-H., Rhee, Y.-H., Park, J.-L., Kim, H.-J., Lee, D., Lee, D., Kim, S.-Y., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt453 · Cited by 98 · see citing works
Mills, J. D., Nalpathamkalam, T., Jacobs, H. I. L., Janitz, C., Merico, D., Hu, P., & Janitz, M. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2012.12.042 · Cited by 82 · see citing works
Pistollato, F., Ohayon, E. L., Lam, A., Langley, G. R., Novak, T. J., Pamies, D., Perry, G. L., Trushina, E. V., Williams, R. S. B., Roher, A. E., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9175 · Cited by 78 · see citing works
Global DNA methylation remodeling during direct reprogramming of fibroblasts to neurons
Luo, C., Lee, Q. Y., Wapinski, O., Castanon, R., Nery, J. R., Mall, M., Kareta, M. S., Cullen, S. M., Goodell, M. A., Chang, H. Y., et al. (2019) · eLife · doi:10.7554/elife.40197 · Cited by 76 · see citing works
Understanding the cause of sporadic Alzheimer’s disease
Zetterberg, H., & Mattsson, N. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.915740 · Cited by 73 · see citing works
Arendt, T., Holzer, M., Stöbe, A., GÄRTNER, U., Lüth, H., Brückner, M. K., & Ueberham, U. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06931.x · Cited by 72 · see citing works
Dedifferentiation and neuronal repression define familial Alzheimer’s disease
Caldwell, A. B., Liu, Q., Schroth, G. P., Galasko, D. R., Yuan, S. H., Wagner, S. L., & Subramaniam, S. (2020) · Science Advances · doi:10.1126/sciadv.aba5933 · Cited by 69 · see citing works
Self-citationHerdy, J., Schafer, S., Kim, Y., Ansari, Z., Zangwill, D., Ku, M., Paquola, A., Lee, H., Mertens, J., & Gage, F. H. (2019) · eLife · doi:10.7554/elife.41356 · Cited by 64 · see citing works
Self-citationMertens, J., Stüber, K., Wunderlich, P., Ladewig, J., Kesavan, J., Vandenberghe, R. R., Vandenbulcke, M., Damme, P. V., Walter, J., Brüstle, O., et al. (2013) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.10.011 · Cited by 60 · see citing works
Self-citationNext‐generation disease modeling with direct conversion: a new path to old neurons
Traxler, L., Edenhofer, F., & Mertens, J. (2019) · FEBS Letters · doi:10.1002/1873-3468.13678 · Cited by 55 · see citing works
Self-citationHorvath, S., Lu, A. T.-H., Cohen, H., & Raj, K. (2019) · Aging · doi:10.18632/aging.101976 · Cited by 51 · see citing works
Self-citationSmith, D. S., Leone, G. W., DeGregori, J. V., Ahmed, M., Qumsiyeh, M. Β., & Nevins, J. R. (2000) · PubMed · Cited by 47 · see citing works
Kim, H. J., Denli, A. M., Wright, R., Baul, T. D., Clemenson, G. D., Morcos, A. S., Zhao, C., Schafer, S. T., Gage, F. H., & Kagalwala, M. N. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4286-14.2015 · Cited by 45 · see citing works
Self-citationEmbryonic Stem Cell–Based Modeling of Tau Pathology in Human Neurons
Mertens, J., Stüber, K., Poppe, D., Doerr, J., Ladewig, J., Brüstle, O., & Koch, P. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.01.043 · Cited by 44 · see citing works
Self-citationRe-expression of cell cycle markers in aged neurons and muscles: Whether cells should divide or die?
Sharma, R. R., Kumar, D., Jha, N. K., Jha, S. K., Ambasta, R. K., & Kumar, P. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.09.010 · Cited by 42 · see citing works
Wagner, I., Wang, H., Weissert, P. M., Straube, W. L., Shevchenko, A., Gentzel, M., Brito, G., Tazaki, A., Oliveira, C. R., Sugiura, T., et al. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.03.002 · Cited by 41 · see citing works
Aging: Somatic Mutations, Epigenetic Drift and Gene Dosage Imbalance.
Veitia, R., Govindaraju, D., Bottani, S., & Birchler, J. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.11.006 · Cited by 37 · see citing works
DNA damage triggers reprogramming of differentiated cells into stem cells in Physcomitrella
Gu, N., Tamada, Y., Imai, A., Pálfalvi, G., Kabeya, Y., Shigenobu, S., Ishikawa, M., Angelis, K. J., Chen, C., & Hasebe, M. (2020) · Nature Plants · doi:10.1038/s41477-020-0745-9 · Cited by 36 · see citing works
Primary neurons can enter M-phase
Walton, C. C., Zhang, W., Patiño-Parrado, I., Barrio-Alonso, E., Garrido, J. J., & Frade, J. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-40462-4 · Cited by 34 · see citing works
Satoh, J., Kawana, N., & Yamamoto, Y. (2013) · Bioinformatics and Biology Insights · doi:10.4137/bbi.s13279 · Cited by 33 · see citing works
Modeling motor neuron disease: the matter of time
Arbab, M., Baars, S., & Geijsen, N. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.07.008 · Cited by 33 · see citing works
Zhang, S., Moy, W., Zhang, H., Leites, C., McGowan, H., Shi, J., Sanders, A. R., Pang, Z. P., Gejman, P. V., & Duan, J. (2018) · Stem Cell Research · doi:10.1016/j.scr.2018.03.014 · Cited by 21 · see citing works
Human neurons to model aging: A dish best served old
Böhnke, L., Traxler, L., Herdy, J. R., & Mertens, J. (2018) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2019.01.001 · Cited by 21 · see citing works
Self-citationMolecular and cellular pathology of monogenic Alzheimer’s disease at single cell resolutionPreprint
Marinaro, F., Haneklaus, M., Zhang, Z., Strano, A., Evans, L., Handfield, L., Ryan, N. S., Fox, N. C., Hemberg, M., Ramanathan, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.14.202317 · Cited by 18 · see citing works
Flagged first, then by citations
1 of the 110 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications
Cerneckis, J., Cai, H., & Shi, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01809-0 · Cited by 452 · see citing works
Cholesterol and matrisome pathways dysregulated in astrocytes and microglia
TCW, J., Qian, L., Pipalia, N. H., Chao, M. J., Liang, S. A., Shi, Y., Jain, B. R., Bertelsen, S. E., Kapoor, M., Marcora, E., et al. (2022) · Cell · doi:10.1016/j.cell.2022.05.017 · Cited by 411 · see citing works
Neuronal cell death mechanisms in Alzheimer’s disease: An insight
Goel, P., Chakrabarti, S., Goel, K., Bhutani, K., Chopra, T., & Bali, S. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.937133 · Cited by 242 · see citing works
MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer’s disease
Balusu, S., Horré, K., Thrupp, N., Craessaerts, K., Snellinx, A., Serneels, L., T’Syen, D., Chrysidou, I., Arranz, A. M., Sierksma, A. S. R., et al. (2023) · Science · doi:10.1126/science.abp9556 · Cited by 234 · see citing works
Herdy, J. R., Traxler, L., Agarwal, R. K., Karbacher, L., Schlachetzki, J. C. M., Boehnke, L., Zangwill, D., Galasko, D., Glass, C. K., Mertens, J., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.11.010 · Cited by 208 · see citing works
Self-citationiPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders
Okano, H., & Morimoto, S. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.01.007 · Cited by 203 · see citing works
Epigenomic dissection of Alzheimer’s disease pinpoints causal variants and reveals epigenome erosion
Xiong, X., James, B. T., Boix, C. A., Park, Y. P., Galani, K., Victor, M. B., Sun, N., Hou, L., Ho, L.-L., Mantero, J., et al. (2023) · Cell · doi:10.1016/j.cell.2023.08.040 · Cited by 205 · see citing works
Traxler, L., Herdy, J. R., Stefanoni, D., Eichhorner, S., Pelucchi, S., Szücs, A., Santagostino, A., Kim, Y., Agarwal, R. K., Schlachetzki, J. C. M., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.07.014 · Cited by 179 · see citing works
Self-citationAdult hippocampal neurogenesis in Alzheimer’s disease: A roadmap to clinical relevance
Salta, E., Lazarov, O., Fitzsimons, C. P., Tanzi, R. E., Lucassen, P. J., & Choi, S. H. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.01.002 · Cited by 165 · see citing works
Microglial lipid droplet accumulation in tauopathy brain is regulated by neuronal AMPK
Li, Y., Munoz-Mayorga, D., Nie, Y., Kang, N., Tao, Y., Lagerwall, J., Pernaci, C., Curtin, G., Coufal, N. G., Mertens, J., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.03.014 · Cited by 160 · see citing works
Self-citationThe interaction between ageing and Alzheimer's disease: insights from the hallmarks of ageing
Liu, Y., Tan, Y., Zhang, Z., Yi, M., Zhu, L., & Peng, W. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00397-x · Cited by 151 · see citing works
Direct neuronal reprogramming: Fast forward from new concepts toward therapeutic approaches
Bocchi, R., Masserdotti, G., & Götz, M. (2021) · Neuron · doi:10.1016/j.neuron.2021.11.023 · Cited by 128 · see citing works
Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease
Welch, G., & Tsai, L. (2022) · The EMBO Reports · doi:10.15252/embr.202154217 · Cited by 129 · see citing works
Barák, M., Fedorová, V., Pospíšilová, V., Raška, J., Vochyánová, S., Sedmík, J., Hříbková, H., Klímová, H., Váňová, T., & Bohačiaková, D. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10254-3 · Cited by 100 · see citing works
Proteostasis and lysosomal repair deficits in transdifferentiated neurons of Alzheimer’s disease
Chou, C.-C., Vest, R., Prado, M. A., Wilson-Grady, J., Paulo, J. A., Shibuya, Y., Moran-Losada, P., Lee, T.-T., Luo, J., Gygi, S. P., et al. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01623-y · Cited by 94 · see citing works
Welch, G. M., Boix, C. A., Schmauch, E., Davila-Velderrain, J., Victor, M. B., Dileep, V., Bozzelli, P. L., Su, Q., Cheng, J. D., Lee, A., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo4662 · Cited by 84 · see citing works
Human neuronal maturation comes of age: cellular mechanisms and species differences
Wallace, J. L., & Pollen, A. A. (2024) · Nature Reviews Neuroscience · doi:10.1038/s41583-023-00760-3 · Cited by 82 · see citing works
Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming
Sun, Z., Kwon, J.-S., Ren, Y., Chen, S., Walker, C. K., Lu, X., Cates, K., Karahan, H., Sviben, S., Fitzpatrick, J. A. J., et al. (2024) · Science · doi:10.1126/science.adl2992 · Cited by 77 · see citing works
“These results underscore the potential of 3D neuronal reprogramming to model age-dependent A β deposition in LOAD neurons.”
Váňová, T., Sedmík, J., Raška, J., Černá, K. A., Tauš, P., Pospisilova, V., Nezvedová, M., Fedorová, V., Kadakova, S., Klímová, H., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113310 · Cited by 76 · see citing works
Integrated transcriptome landscape of ALS identifies genome instability linked to TDP-43 pathology
Ziff, O. J., Neeves, J., Mitchell, J. S., Tyzack, G. E., Martínez‐Ruiz, C., Luisier, R., Chakrabarti, A. M., McGranahan, N., Litchfield, K., Boulton, S. J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37630-6 · Cited by 71 · see citing works
Therapeutic targeting of senescent cells in the CNS
Rießland, M., Ximerakis, M., Jarjour, A. A., Zhang, B., & Orr, M. E. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01033-z · Cited by 76 · see citing works
Capano, L. S., Sato, C., Ficulle, E., Yu, A., Horie, K., Kwon, J.-S., Burbach, K. F., Barthélemy, N. R., Fox, S. G., Karch, C. M., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.04.018 · Cited by 65 · see citing works
Ji, Y., Chen, X., Wang, Z., Meek, C. J., McLean, J. L., Yang, Y., Yuan, C., Rochet, J., Liu, F., & Xu, R. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03041-w · Cited by 67 · see citing works
The future of stem cell therapies of Alzheimer’s disease
Wang, Z., Wang, Z.-T., Sun, Y., Tan, L., & Yu, J. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101655 · Cited by 62 · see citing works
Ring, N., Valdivieso, K., Grillari, J., Redl, H. R., & Ogrodnik, M. B. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.04.005 · Cited by 59 · see citing works
Stern, S., Lau, S., Manole, A., Rosh, I., Percia, M. M., Ezer, R. B., Shokhirev, M. N., Qiu, F., Schafer, S. T., Mansour, A. A., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00366-z · Cited by 58 · see citing works
Self-citationSaurat, N. G., Minotti, A. P., Rahman, M. T., Sikder, T., Zhang, C., Cornacchia, D., Jungverdorben, J., Ciceri, G., Betel, D., & Studer, L. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.06.001 · Cited by 58 · see citing works
Metabolism navigates neural cell fate in development, aging and neurodegeneration
Traxler, L., Lagerwall, J., Eichhorner, S., Stefanoni, D., D’Alessandro, A., & Mertens, J. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048993 · Cited by 57 · see citing works
Self-citationAltered Extracellular Vesicle miRNA Profile in Prodromal Alzheimer’s Disease
Visconte, C., Fenoglio, C., Serpente, M., Muti, P. C., Sacconi, A., Rigoni, M., Arighi, A., Borracci, V., Arcaro, M., Arosio, B., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914749 · Cited by 54 · see citing works
Neurodegeneration cell per cell
Balusu, S., Praschberger, R., Lauwers, E., Strooper, B. D., & Verstreken, P. (2023) · Neuron · doi:10.1016/j.neuron.2023.01.016 · Cited by 51 · see citing works
Alzheimer’s disease and related tauopathies: disorders of disrupted neuronal identity
Frost, B. E. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.07.006 · Cited by 56 · see citing works
Cellular plasticity in reprogramming, rejuvenation and tumorigenesis: a pioneer TF perspective
Huyghe, A., Trajkova, A., & Lavial, F. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.07.013 · Cited by 55 · see citing works
Cellular reprogramming as a tool to model human aging in a dish
Pitrez, P. R., Monteiro, L. M., Borgogno, O., Nissan, X., Mertens, J., & Ferreira, L. (2024) · Nature Communications · doi:10.1038/s41467-024-46004-5 · Cited by 49 · see citing works
Self-citationDrouin‐Ouellet, J., Legault, E. M., Nilsson, F., Pircs, K., Bouquety, J., Petit, F., Shrigley, S., Birtele, M., Pereira, M., Storm, P., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.08.010 · Cited by 47 · see citing works
Namboori, S. C., Thomas, P., Ames, R. M., Hawkins, S., Garrett, L. O., Willis, C. R. G., Rosa, A., Stanton, L. W., & Bhinge, A. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.10.010 · Cited by 38 · see citing works
Rosh, I., Tripathi, U., Hussein, Y., Rike, W. A., Djamus, J., Shklyar, B., Manole, A., Houlden, H., Winkler, J., Gage, F. H., et al. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00653-x · Cited by 37 · see citing works
Self-citationSenopathies-Diseases Associated with Cellular Senescence
Lushchak, O., Schosserer, M., & Grillari, J. (2023) · Biomolecules · doi:10.3390/biom13060966 · Cited by 35 · see citing works
Tools for studying human microglia: In vitro and in vivo strategies
Warden, A. S., Han, C. Z., Hansen, E. A., Trescott, S., Nguyen, C. T., Kim, R. Y., Schafer, D. M., Johnson, A., Wright, M., Ramírez, G., et al. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.10.008 · Cited by 36 · see citing works
Strategies for modeling aging and age-related diseases
Jothi, D., & Kulka, L. A. M. (2024) · npj Aging · doi:10.1038/s41514-024-00161-5 · Cited by 36 · see citing works
Neural cell state shifts and fate loss in ageing and age-related diseases
Traxler, L., Lucciola, R., Herdy, J. R., Jones, J. R., Mertens, J., & Gage, F. H. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00815-0 · Cited by 36 · see citing works
Self-citationPiperidine: A Versatile Heterocyclic Ring for Developing Monoamine Oxidase Inhibitors
Jayan, J., Chandran, N., Thekkantavida, A. C., Abdelgawad, M. A., Ghoneim, M. M., Shaker, M. E., Uniyal, P., Benny, F., Zachariah, S. M., Kumar, S., et al. (2023) · ACS Omega · doi:10.1021/acsomega.3c05883 · Cited by 34 · see citing works
Current Position and Future Direction of Inflammation in Neuropsychiatric Disorders
Upthegrove, R., Zuelli, F. M. D. G. C., Couch, A. C. M., Barnes, N. M., & Vernon, A. C. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.1369 · Cited by 37 · see citing works
Integration of iPSC-Derived Microglia into Brain Organoids for Neurological Research
Mrza, M. A., He, J., & Wang, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063148 · Cited by 31 · see citing works
Aversano, S., Caiazza, C., & Caiazzo, M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1069482 · Cited by 33 · see citing works
Guo, W., Wang, H., Tharkeshwar, A. K., Couthouis, J., Braems, E., Masrori, P., Schoor, E. V., Fan, Y., Ahuja, K., Moisse, M., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12760 · Cited by 31 · see citing works
Weigel, B., Tegethoff, J. F., Grieder, S. D., Lim, B., Nagarajan, B., Liu, Y.-C., Truberg, J., Papageorgiou, D., Adrian-Segarra, J. M., Schmidt, L. K., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01959-7 · Cited by 31 · see citing works
Wang, X., Ding, C., & Li, H. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2376-0 · Cited by 29 · see citing works
Maiden voyage: induced pluripotent stem cell-based drug screening for amyotrophic lateral sclerosis
Ito, D., Morimoto, S., Takahashi, S., Okada, K., Nakahara, J., & Okano, H. (2022) · Brain · doi:10.1093/brain/awac306 · Cited by 28 · see citing works
Tripathi, U., Rosh, I., Ezer, R. B., Nayak, R., Hussein, Y., Choudhary, A., Djamus, J., Manole, A., Houlden, H., Gage, F. H., et al. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00715-0 · Cited by 34 · see citing works
Self-citationProgress and challenges in directing the differentiation of human iPSCs into spinal motor neurons
Bautista, C. M. C., & Sterneckert, J. L. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1089970 · Cited by 27 · see citing works
Modeling Alzheimer’s disease using human cell derived brain organoids and 3D models
Fernandes, S., Revanna, J. S., Pratt, J. M., Hayes, N., Marchetto, M. C., & Gage, F. H. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1434945 · Cited by 33 · see citing works
Self-citationExperimental modeling of Alzheimer's disease: Translational lessons from cross‐taxon analyses
Yenkoyan, K. B., Kotova, M. M., Apukhtin, K. V., Galstyan, D. S., Amstislavskaya, T. G., Strekalova, T. V., de Abreu, M. S., Chavushyan, V. A., Lim, L. W., Yang, L., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70273 · Cited by 30 · see citing works
NF-κB in Alzheimer’s Disease: Friend or Foe? Opposite Functions in Neurons and Glial Cells
Kaltschmidt, B., Czaniera, N. J., Schulten, W., & Kaltschmidt, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111353 · Cited by 26 · see citing works
Hudson, H. R., Sun, X., & Orr, M. E. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00519 · Cited by 28 · see citing works
Distinct systemic impacts of Aβ42 and Tau revealed by whole-organism snRNA-seq
Park, Y.-J., Lu, T., Jackson, T., Goodman, L. D., Ran, L., Chen, J., Liang, C., Harrison, E. M., Ko, C., Chen, X. X., et al. (2024) · Neuron · doi:10.1016/j.neuron.2025.04.017 · Cited by 25 · see citing works
Current status and future directions of clinical applications using iPS cells—focus on Japan
Tsujimoto, H., & Osafune, K. (2021) · FEBS Journal · doi:10.1111/febs.16162 · Cited by 25 · see citing works
Transcriptomic profiling of sporadic Alzheimer’s disease patients
Caldwell, A. B., Anantharaman, B. G., Ramachandran, S., Nguyen, P. A. H., Liu, Q., Trinh, I., Galasko, D. R., Desplats, P., Wagner, S. L., & Subramaniam, S. (2022) · Molecular Brain · doi:10.1186/s13041-022-00963-2 · Cited by 25 · see citing works
Self-citationBeckmann, A., Ramirez, P., Gamez, M., Gonzalez, E. M., Mange, J. D., Bieniek, K. F., Ray, W. J., & Frost, B. E. (2023) · iScience · doi:10.1016/j.isci.2023.106152 · Cited by 24 · see citing works
Monozygotic twins discordant for schizophrenia differ in maturation and synaptic transmission
Stern, S., Zhang, L., Wang, M., Wright, R., Rosh, I., Hussein, Y., Stern, T., Choudhary, A., Tripathi, U., Reed, P., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02561-1 · Cited by 23 · see citing works
Self-citationKim, H., Kim, S., Cho, B., Shin, J., & Kim, J. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00319-9 · Cited by 22 · see citing works
Human brain organoids to explore SARS‐CoV‐2‐induced effects on the central nervous system
Ostermann, P. N., & Schaal, H. (2023) · Reviews in Medical Virology · doi:10.1002/rmv.2430 · Cited by 22 · see citing works
Iqbal, M. A., Bilen, M., Liu, Y., Jabre, V., Fong, B. C., Chakroun, I., Paul, S., Chen, J., Wade, S., Kanaan, M., et al. (2024) · Aging Cell · doi:10.1111/acel.14165 · Cited by 22 · see citing works
Österlund, N., Frankel, R., Carlsson, A., Thacker, D., Karlsson, M., Matus, V., Gräslund, A., Emanuelsson, C. S., & Linse, S. S. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105317 · Cited by 22 · see citing works
Sommer, D., Rajkumar, S., Seidel, M., Aly, A., Ludolph, A. C., Ho, R., Boeckers, T. M., & Catanese, A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.894230 · Cited by 20 · see citing works
Pinpointing the locus of GABAergic vulnerability in Alzheimer’s disease
Melgosa-Ecenarro, L., Doostdar, N., Radulescu, C. I., Jackson, J., & Barnes, S. J. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.06.017 · Cited by 20 · see citing works
Defining and characterizing neuronal senescence, ‘neurescence’, as GX arrested cells
Hudson, H. R., Rießland, M., & Orr, M. E. (2024) · Trends in Neurosciences · doi:10.1016/j.tins.2024.09.006 · Cited by 21 · see citing works
Valdes, P., Caldwell, A. B., Liu, Q., Fitzgerald, M. Q., Ramachandran, S., Karch, C. M. M., Dominantly Inherited Alzheimer Network (DIAN), Adams, S., Allegri, R., Araki, A., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01659-6 · Cited by 21 · see citing works
Kim, H., Kang, S., Cho, B., An, S., Kim, Y.-K., & Kim, J. (2025) · Advanced Science · doi:10.1002/advs.202412548 · Cited by 19 · see citing works
Cell Reprogramming for Regeneration and Repair of the Nervous System
Clark, I. H., Roman, A., Fellows, E., Radha, S., Var, S. R., Roushdy, Z., Borer, S. M., Johnson, S., Chen, O. M., Borgida, J. S. W., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10102598 · Cited by 20 · see citing works
Weng, M., Hu, H., Graus, M. S., Tan, D. S., Gao, Y., Ren, S., Ho, D. H. H., Langer, J., Holzner, M., Huang, Y., et al. (2023) · Science Advances · doi:10.1126/sciadv.adh2501 · Cited by 19 · see citing works
Engineering Innervated Musculoskeletal Tissues for Regenerative Orthopedics and Disease Modeling
Zhou, Z., Liu, J., Xiong, T., Liu, Y., Tuan, R. S., & Li, Z. A. (2024) · Small · doi:10.1002/smll.202310614 · Cited by 19 · see citing works
Epigenetic control and manipulation of neuronal maturation timing
Ciceri, G., & Studer, L. (2024) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2024.102164 · Cited by 18 · see citing works
Ceccarelli, D. C., & Solerte, S. B. (2025) · Metabolites · doi:10.3390/metabo15030159 · Cited by 17 · see citing works
Kajtez, J., Nilsson, F., Laurin, K., Bruzelius, A., Cepeda-Prado, E., Birtele, M., Barker, R. A., Herborg, F., Ottosson, D. R., Storm, P., et al. (2025) · Science Advances · doi:10.1126/sciadv.adq7855 · Cited by 16 · see citing works
Cell models for Down syndrome-Alzheimer’s disease research
Wu, Y., West, N. R., Bhattacharyya, A., & Wiseman, F. K. (2022) · Neuronal Signaling · doi:10.1042/ns20210054 · Cited by 17 · see citing works
Genotoxic Damage During Brain Development Presages Prototypical Neurodegenerative Disease
Kisby, G. E., & Spencer, P. S. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.752153 · Cited by 17 · see citing works
A cellular identity crisis? Plasticity changes during aging and rejuvenationPreprint
Gorelov, R. A., & Hochedlinger, K. (2024) · Genes & Development · doi:10.1101/gad.351728.124 · Cited by 18 · see citing works
Phospho-Tau and Chromatin Landscapes in Early and Late Alzheimer’s Disease
Gil, L., Niño, S. A., Guerrero, C., & Jiménez-Capdeville, M. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910283 · Cited by 15 · see citing works
Quéré, M., Alberto, J., Broly, F., Hergalant, S., Christov, C., Gauchotte, G., Guéant, J., Namour, F., & Battaglia-Hsu, S.-F. (2022) · Nutrients · doi:10.3390/nu14091887 · Cited by 16 · see citing works
Trigeminal Neuralgia Is a Dementia Risk Factor: A Retrospective Cohort Study
Cheng, Y.-H., Wu, C., Wang, W., Lu, Y., & Wu, M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19106073 · Cited by 16 · see citing works
Endotype reversal as a novel strategy for screening drugs targeting familial Alzheimer's disease
Caldwell, A. B., Liu, Q., Zhang, C. M., Schroth, G. P., Galasko, D. R., Rynearson, K. D., Tanzi, R. E., Yuan, S. H., Wagner, S. L., & Subramaniam, S. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12553 · Cited by 15 · see citing works
Self-citationA new age in understanding adult hippocampal neurogenesis in Alzheimer’s disease
Hanspal, M. A., & Gillotin, S. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.339472 · Cited by 11 · see citing works
Zhu, B., Fisher, E., Li, L., Zhong, P., Yan, Z., & Feng, J. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.09.012 · Cited by 14 · see citing works
Modeling APOE ε4 familial Alzheimer’s disease in directly converted 3D brain organoids
Kim, Y.-K., Kim, H., Cho, B., An, S., Kang, S., Kim, S., & Kim, J. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1435445 · Cited by 14 · see citing works
Supakul, S., Okano, H., & Maeda, S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.768948 · Cited by 15 · see citing works
Antón‐Fernández, A., de Alegría, Á. R., Mariscal-Casero, A., Roldán-Lázaro, M., Peinado-Cahuchola, R., Ávila, J., & Hernández, F. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102743 · Cited by 13 · see citing works
Research models to study lewy body dementia
Boschen, S. L., Mukerjee, A. A., Faroqi, A. H., Rabichow, B. E., & Fryer, J. D. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00837-w · Cited by 15 · see citing works
Human fetal tissue is critical for biomedical research
Brumbaugh, J., Aguado, B. A., Lysaght, T., & Goldstein, L. S. B. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.10.008 · Cited by 13 · see citing works
Self-citationMacMullen, C., Sharma, N., & Davis, R. L. (2024) · Brain · doi:10.1093/brain/awae364 · Cited by 13 · see citing works
Provasek, V. E., Bacolla, A., Rangaswamy, S., Kodavati, M. M., Mitra, J., Yusuf, I. O., Malojirao, V. H., Vasquez, V., Britz, G. W., Li, G., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf920 · Cited by 13 · see citing works
Mollinari, C., Dominicis, C. D., Lupacchini, L., Sansone, L., Caprini, D., Casciola, C. M., Wang, Y., Zhao, J., Fini, M., Russo, M. A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042147 · Cited by 13 · see citing works
Tosoni, G., Ayyildiz, D., Snoeck, S., Moreno‐Jiménez, E. P., Penning, A., Santiago-Mujika, E., Ormaechea, O. R., Lee, H., Poovathingal, S. K., Davie, K., et al. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.04.002 · Cited by 13 · see citing works
Self-citationWu, H., Wang, J., Hu, X., Zhuang, C., Zhou, J., Wu, P., Li, S., & Zhao, R. C. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1191680 · Cited by 12 · see citing works
Qu, W., Lam, M., McInvale, J. J., Mares, J. A., Kwon, S. H., Humala, N., Mahajan, A., Nguyen, T. T. T., Jakubiak, K. A., Mun, J.-Y., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02755-5 · Cited by 13 · see citing works
Maksour, S., & Ooi, L. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15885 · Cited by 11 · see citing works
Gil, L., Chi-Ahumada, É., Niño, S. A., Capdeville, G., Méndez-Torres, A. M., Guerrero, C., Poves, A. B. R., Olazabal, I. M., & Jiménez-Capdeville, M. E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112873 · Cited by 10 · see citing works
Yoon, L., Botham, R. C., Verhelle, A., Wu, Y., Cole, C. M., Tan, E. P., Massey, L. A., Sanz-Martinez, P., Chou, C., Xu, J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.29.509997 · Cited by 11 · see citing works
Ma, L., Wei, Q., Jiang, M., Wu, Y.-Y., Liu, X., Yang, Q., Bai, Z.-T., & Yang, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136105 · Cited by 11 · see citing works
Approaches for studying neuroimmune interactions in Alzheimer’s disease
Lin, C., Tian, Y., Tanzi, R. E., & Jorfi, M. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.10.002 · Cited by 10 · see citing works
Cates, K., Yuan, L., Yang, Y., & Yoo, A. S. J. (2025) · Cell Reports · doi:10.1016/j.celrep.2024.115153 · Cited by 11 · see citing works
- Authors
- Mertens, J., Herdy, J. R., Traxler, L., Schafer, S. T., Schlachetzki, J. C. M., Böhnke, L., Reid, D. A., Lee, H., Zangwill, D., Fernandes, D. P., Agarwal, R. K., Lucciola, R., Zhou-Yang, L., Karbacher, L., Edenhofer, F., Stern, S., Horvath, S., Paquola, A. C. M., Glass, C. K., Yuan, S. H., Ku, M., Szücs, A., Goldstein, L. S. B., Galasko, D., & Gage, F. H.
- Affiliations
- Salk Institute for Biological Studies (US)
- University of California San Diego (US)
- Universität Innsbruck (AT)
- University of California, Los Angeles (US)
- University of Minnesota (US)
- University of Freiburg (DE)
- Corresponding author
- Gage, Fred H.
- ORCID
- Venue
- Cell Stem Cell
- Publisher
- Elsevier BV
- Published
- 2021-09
- Volume
- 28
- Issue
- 9
- Pages
- 1533-1548.e6
- ISSN
- 1875-9777 (ISSN-L)
- 1934-5909
- PMC
- PMC8423435
- OpenAlex
- W3157334032
- Semantic Scholar
- 8048718b1b52a70eeaec2916188b07119caa46f5
- Cited by
- 240
- References
- 110
- Citations by year
- 2026: 34 · 2025: 45 · 2024: 54 · 2023: 54 · 2022: 42 · 2021: 11
- FWCI
- 13.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cell stem cell (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- ELTE Digital Institutional Repository (EDIT) (Eötvös Loránd University) (submittedVersion, other-oa)
- Funders
- Leona M. and Harry B. Helmsley Charitable Trust
- University of California, San Diego
- Marshallplan-Jubiläumsstiftung
- Deutsche Forschungsgemeinschaft
- Austrian Science Fund (ANN-135291)
- BrightFocus Foundation
- Bundesministerium für Bildung, Wissenschaft, Forschung und Technologie
- Alzheimer's Disease Research Center, Emory University
- Alzheimer Nederland
- European Commission (ERC-STG-2019-852086, H2020-MSCA-IF-2017-797205)
- Alzheimer's Association
- Deutscher Akademischer Austauschdienst
- American Heart Association
- G. Harold and Leila Y. Mathers Charitable Foundation
- Allen Foundation (19PABH134610000)
- National Institutes of Health (AG056306, AG056511, AG057706, AG062429)
- European Research Council
- National Institute on Aging (K99-AG056679)
- Horizon 2020 Marie Skłodowska-Curie Actions
- EU Joint Programme – Neurodegenerative Disease Research
- California Institute for Regenerative Medicine (RT2-01927)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- Alzheimer's disease, induced neurons, neuronal identity, neuronal maturation, fibroblast-to-neuron conversion, iPSC-derived neurons, epigenetic clocks, dedifferentiation, neuronal transcriptome
- MeSH terms
- Aged, Aging, Alzheimer Disease, Fibroblasts, Humans, Neurons, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review